|
COBISS.SI-ID |
Title of the work |
Type |
Source |
Year |
Database |
CI |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
1. |
2249073 |
Cytoplasmic steps of peptidoglycan biosynthesis |
1.02 |
FEMS microbiol. rev. |
2008 |
WoS |
303 |
22 |
19 |
23 |
22 |
29 |
27 |
34 |
41 |
41 |
45 |
0 |
Scopus |
332 |
23 |
20 |
29 |
23 |
30 |
30 |
34 |
48 |
48 |
45 |
2 |
2. |
3299185 |
Antioxidant and antimicrobial activities of cinnamic acid derivatives |
1.02 |
Mini rev. med. chem. |
2012 |
WoS |
283 |
4 |
11 |
17 |
19 |
23 |
30 |
38 |
47 |
51 |
43 |
|
Scopus |
299 |
4 |
11 |
17 |
20 |
25 |
31 |
39 |
54 |
50 |
45 |
3 |
3. |
22940455 |
Electrically tunable liquid crystal optical microresonators |
1.01 |
Nat. photonics |
2009 |
WoS |
222 |
24 |
27 |
15 |
25 |
27 |
17 |
30 |
22 |
24 |
10 |
1 |
Scopus |
230 |
22 |
28 |
17 |
24 |
29 |
18 |
32 |
22 |
25 |
11 |
2 |
4. |
2548337 |
Rhodanine as a privileged scaffold in drug discovery |
1.02 |
Curr. med. chem. |
2009 |
WoS |
178 |
11 |
23 |
25 |
13 |
15 |
18 |
15 |
22 |
22 |
14 |
|
Scopus |
195 |
15 |
23 |
26 |
15 |
17 |
19 |
13 |
29 |
24 |
14 |
|
5. |
3713393 |
Discovery, biological evaluation, and crystal structure of a novel nanomolar selective
butyrylcholinesterase inhibitor |
1.01 |
J. med. chem. |
2014 |
WoS |
179 |
|
|
2 |
16 |
21 |
21 |
30 |
29 |
34 |
26 |
|
Scopus |
184 |
|
|
2 |
16 |
22 |
21 |
32 |
31 |
32 |
26 |
2 |
6. |
3690609 |
Bioactivation potential of thiophene-containing drugs |
1.01 |
Chem. res. toxicol. |
2014 |
WoS |
162 |
|
|
11 |
11 |
19 |
31 |
22 |
32 |
19 |
15 |
2 |
Scopus |
165 |
|
|
10 |
12 |
18 |
32 |
18 |
39 |
19 |
14 |
3 |
7. |
2746993 |
Review of operating principle and applications of the charged aerosol detector |
1.02 |
J. chromatogr., A |
2010 |
WoS |
128 |
19 |
11 |
9 |
17 |
13 |
9 |
15 |
13 |
13 |
9 |
|
Scopus |
143 |
18 |
11 |
13 |
19 |
18 |
9 |
17 |
12 |
14 |
11 |
1 |
8. |
3238001 |
Rhodanine as a scaffold in drug discovery: a critical review of its biological activities
and mechanisms of target modulation |
1.02 |
Expert opinion on drug discovery |
2012 |
WoS |
121 |
12 |
11 |
9 |
15 |
16 |
15 |
13 |
4 |
12 |
14 |
|
Scopus |
129 |
12 |
12 |
10 |
14 |
17 |
17 |
14 |
6 |
12 |
15 |
|
9. |
2770545 |
C-type lectin DC-SIGN; an adhesion, signalling and antigen-uptake molecule that guides
dendritic cells in immunity |
1.02 |
Cell. signal. |
2010 |
WoS |
116 |
17 |
18 |
12 |
13 |
15 |
8 |
9 |
9 |
12 |
3 |
|
Scopus |
127 |
19 |
18 |
13 |
17 |
15 |
8 |
9 |
10 |
13 |
5 |
|
10. |
4785492 |
Effect of cell electroporation on the conductivity of a cell suspension |
1.01 |
Biophys. j. |
2005 |
WoS |
107 |
7 |
12 |
10 |
15 |
10 |
10 |
9 |
14 |
10 |
10 |
|
Scopus |
127 |
10 |
11 |
11 |
18 |
19 |
11 |
9 |
15 |
13 |
10 |
|
11. |
4184177 |
Bisphenol A and its analogs |
1.02 |
Environ Toxicol Pharmacol |
2016 |
WoS |
113 |
|
|
|
|
7 |
16 |
17 |
27 |
25 |
21 |
|
Scopus |
118 |
|
|
|
|
6 |
18 |
19 |
25 |
25 |
21 |
4 |
12. |
4882801 |
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant
tumors |
1.02 |
Drug resist. updat. |
2020 |
WoS |
110 |
|
|
|
|
|
|
|
13 |
40 |
54 |
3 |
Scopus |
115 |
|
|
|
|
|
|
|
13 |
43 |
53 |
6 |
13. |
2354289 |
EANM/ESC guidelines for radionuclide imaging of cardiac function |
1.02 |
Eur. j. nucl. med. mol. imaging |
2008 |
WoS |
101 |
8 |
16 |
12 |
6 |
9 |
12 |
7 |
13 |
10 |
8 |
|
Scopus |
112 |
11 |
22 |
14 |
7 |
7 |
15 |
8 |
14 |
5 |
9 |
|
14. |
1761649 |
Recent advances in the synthesis of 2H-1,4-benzoxazin-3-(4H)-ones and 3,4-dihydro-2H-1,4-benzoxazines |
1.02 |
Tetrahedron |
2005 |
WoS |
88 |
14 |
11 |
9 |
8 |
8 |
5 |
5 |
10 |
13 |
3 |
2 |
Scopus |
99 |
14 |
13 |
10 |
9 |
8 |
9 |
7 |
11 |
12 |
4 |
2 |
15. |
19064067 |
Bicyclic boronate VNRX-5133 inhibits metallo- and serine-ß-lactamases |
1.01 |
J. med. chem. |
2019 |
WoS |
93 |
|
|
|
|
|
|
1 |
34 |
32 |
26 |
|
Scopus |
98 |
|
|
|
|
|
|
1 |
36 |
36 |
25 |
|
16. |
2692209 |
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma |
1.02 |
Eur. j. nucl. med. mol. imaging |
2009 |
WoS |
78 |
8 |
13 |
13 |
9 |
8 |
6 |
10 |
5 |
3 |
3 |
|
Scopus |
98 |
11 |
18 |
16 |
12 |
10 |
7 |
9 |
9 |
3 |
3 |
|
17. |
4130929 |
Structural features of subtype-selective EP receptor modulators |
1.02 |
Drug discov. today |
2017 |
WoS |
91 |
|
|
|
|
2 |
17 |
23 |
16 |
22 |
11 |
|
Scopus |
97 |
|
|
|
|
2 |
17 |
26 |
16 |
24 |
11 |
1 |
18. |
3616625 |
Encoded library technology as a source of hits for the discovery and lead optimization
of a potent and selective class of bactericidal direct inhibitors of mycobacterium
tuberculosis inhA |
1.01 |
J. med. chem. |
2014 |
WoS |
85 |
|
4 |
17 |
15 |
10 |
15 |
5 |
10 |
5 |
4 |
|
Scopus |
96 |
|
5 |
18 |
16 |
10 |
16 |
7 |
11 |
7 |
5 |
1 |
19. |
4033905 |
Hazard identification and risk characterization of bisphenols A, F and AF to aquatic
organisms |
1.01 |
Environ. pollut. |
2016 |
WoS |
83 |
|
|
|
2 |
8 |
13 |
12 |
15 |
15 |
18 |
|
Scopus |
91 |
|
|
|
2 |
9 |
13 |
13 |
18 |
15 |
20 |
1 |
20. |
3437937 |
Mutagenicity and DNA damage of bisphenol A and its structural analogs |
1.01 |
Arh. hig. rada toksikol. |
2013 |
WoS |
76 |
|
3 |
1 |
6 |
8 |
14 |
13 |
8 |
13 |
10 |
|
Scopus |
84 |
|
3 |
2 |
7 |
8 |
14 |
11 |
10 |
15 |
13 |
1 |
21. |
1955697 |
Recent progress in diaryl ether synthesis |
1.02 |
Synthesis |
2006 |
WoS |
83 |
19 |
4 |
8 |
10 |
7 |
7 |
6 |
10 |
8 |
4 |
|
Scopus |
81 |
18 |
4 |
7 |
9 |
7 |
5 |
6 |
11 |
8 |
5 |
1 |
22. |
4444017 |
The magic of crystal structure-based Inhibitor optimization |
1.01 |
J. med. chem. |
2018 |
WoS |
78 |
|
|
|
|
|
1 |
17 |
17 |
17 |
24 |
2 |
Scopus |
82 |
|
|
|
|
|
1 |
18 |
17 |
18 |
24 |
4 |
23. |
30884135 |
The occurrence and source identification of bisphenol compounds in wastewaters |
1.01 |
Sci. total environ. |
2018 |
WoS |
74 |
|
|
|
|
|
4 |
16 |
15 |
16 |
22 |
1 |
Scopus |
81 |
|
|
|
|
|
5 |
18 |
12 |
19 |
23 |
4 |
24. |
2839153 |
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation
of radiopharmaceuticals |
1.01 |
Eur. j. nucl. med. mol. imaging |
2010 |
WoS |
63 |
1 |
9 |
7 |
1 |
7 |
4 |
9 |
14 |
6 |
4 |
1 |
Scopus |
78 |
1 |
11 |
9 |
4 |
10 |
5 |
10 |
15 |
6 |
6 |
1 |
25. |
3620721 |
Endocrine disruptome - an open source prediction tool for assessing endocrine disruption
potential through nuclear receptor binding |
1.01 |
J. chem. inf. mod. |
2014 |
WoS |
69 |
|
|
4 |
8 |
9 |
4 |
13 |
7 |
13 |
11 |
|
Scopus |
77 |
|
|
4 |
9 |
10 |
3 |
13 |
8 |
13 |
13 |
4 |
26. |
4818033 |
Dual inhibitors of human DNA topoisomerase II and other cancer-related targets |
1.02 |
J. med. chem. |
2020 |
WoS |
69 |
|
|
|
|
|
|
|
6 |
27 |
34 |
2 |
Scopus |
77 |
|
|
|
|
|
|
|
7 |
30 |
38 |
2 |
27. |
10300500 |
Cell electrofusion using nanosecond electric pulses |
1.01 |
Sci. rep. |
2013 |
WoS |
63 |
|
3 |
3 |
6 |
11 |
9 |
11 |
3 |
8 |
8 |
1 |
Scopus |
77 |
|
2 |
4 |
9 |
13 |
10 |
11 |
6 |
13 |
8 |
1 |
28. |
4263537 |
Development of an in-vivo active reversible butyrylcholinesterase inhibitor |
1.01 |
Sci. rep. |
2016 |
WoS |
72 |
|
|
|
|
4 |
6 |
13 |
18 |
14 |
17 |
|
Scopus |
74 |
|
|
|
|
4 |
6 |
13 |
19 |
15 |
15 |
2 |
29. |
4223601 |
Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives
with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation |
1.01 |
Eur. j. med. chem. |
2017 |
WoS |
69 |
|
|
|
|
10 |
15 |
16 |
12 |
9 |
6 |
1 |
Scopus |
74 |
|
|
|
|
10 |
16 |
17 |
13 |
10 |
6 |
2 |
30. |
4309873 |
Xanthine oxidase inhibitors beyond allopurinol and febuxostat |
1.02 |
Eur. j. med. chem. |
2017 |
WoS |
69 |
|
|
|
|
1 |
12 |
11 |
15 |
18 |
12 |
|
Scopus |
73 |
|
|
|
|
1 |
13 |
9 |
15 |
21 |
13 |
1 |
31. |
3969137 |
Glass fiber-supported TiO [sub] 2 photocatalyst |
1.01 |
Appl. catal., B Environ. |
2016 |
WoS |
68 |
|
|
|
6 |
7 |
10 |
13 |
12 |
9 |
9 |
2 |
Scopus |
72 |
|
|
|
6 |
8 |
10 |
12 |
13 |
10 |
10 |
3 |
32. |
2876529 |
Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione
inhibitors of MurD ligase |
1.01 |
J. med. chem. |
2010 |
WoS |
64 |
5 |
13 |
7 |
4 |
6 |
4 |
8 |
9 |
4 |
4 |
|
Scopus |
72 |
5 |
14 |
8 |
4 |
9 |
4 |
8 |
9 |
5 |
6 |
|
33. |
26058457 |
Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin
and C-reactive protein in sepsis of critically ill neonates and children |
1.01 |
Intensive Care Med |
2009 |
WoS |
62 |
14 |
7 |
6 |
9 |
7 |
1 |
7 |
6 |
4 |
1 |
|
Scopus |
72 |
17 |
10 |
8 |
9 |
9 |
1 |
6 |
6 |
4 |
2 |
|
34. |
5092943 |
Genotoxic activity of bisphenol A and its analogues bisphenol S, bisphenol F and bisphenol
AF and their mixtures in human hepatocellular carcinoma (HepG2) cells |
1.01 |
Sci. total environ. |
2019 |
WoS |
60 |
|
|
|
|
|
|
2 |
15 |
25 |
16 |
2 |
Scopus |
68 |
|
|
|
|
|
|
2 |
15 |
26 |
19 |
6 |
35. |
1699631 |
Structural characterization and biological evaluation of a clioquinol-ruthenium complex
with copper- independent antileukaemic activity |
1.01 |
Dalton trans. |
2014 |
WoS |
64 |
|
2 |
8 |
4 |
6 |
7 |
13 |
10 |
9 |
5 |
|
Scopus |
66 |
|
2 |
8 |
4 |
7 |
6 |
13 |
11 |
8 |
6 |
1 |
36. |
2514516 |
The influence of medium conductivity on electropermeabilization and survival of cells
in vitro |
1.01 |
Bioelectrochemistry |
2001 |
WoS |
60 |
3 |
6 |
6 |
3 |
5 |
5 |
9 |
11 |
7 |
4 |
1 |
Scopus |
65 |
3 |
7 |
6 |
3 |
5 |
6 |
9 |
11 |
9 |
3 |
3 |
37. |
4523889 |
Physiologically based pharmacokinetic PBPK modelling of bisphenol BPA, BPS, BPF, and
BPAF with new experimental metabolic parametrics |
1.01 |
Environ. health perspect. |
2018 |
WoS |
59 |
|
|
|
|
|
|
16 |
14 |
15 |
13 |
1 |
Scopus |
64 |
|
|
|
|
|
|
14 |
12 |
17 |
16 |
5 |
38. |
2622577 |
Influence of polymorphism in candidate genes on late cardiac damage in patients treated
due to acute leukemia in childhood |
1.01 |
Leuk. lymphoma |
2009 |
WoS |
63 |
6 |
4 |
4 |
8 |
8 |
9 |
7 |
11 |
5 |
1 |
|
Scopus |
63 |
8 |
4 |
4 |
8 |
8 |
9 |
7 |
10 |
4 |
1 |
|
39. |
1536057027 |
Catalytic oxygenation of sp[sup]3 C-H bonds with Ir(III) complexes of chelating triazoles
and mesoionic carbenes |
1.01 |
Dalton trans. |
2015 |
WoS |
62 |
|
|
11 |
12 |
9 |
6 |
5 |
6 |
9 |
4 |
|
Scopus |
63 |
|
|
11 |
10 |
10 |
6 |
6 |
6 |
9 |
5 |
|
40. |
2904177 |
False positives in the early stages of drug discovery |
1.02 |
Curr. med. chem. |
2010 |
WoS |
63 |
4 |
5 |
8 |
8 |
0 |
4 |
8 |
10 |
9 |
7 |
|
Scopus |
61 |
4 |
5 |
8 |
8 |
0 |
4 |
8 |
12 |
7 |
5 |
|
41. |
4706929 |
Efflux pump inhibitors of clinically relevant multidrug resistant bacteria |
1.02 |
Med. res. rev. |
2019 |
WoS |
61 |
|
|
|
|
|
|
1 |
18 |
19 |
22 |
1 |
Scopus |
62 |
|
|
|
|
|
|
|
20 |
20 |
21 |
1 |
42. |
4144753 |
Novel multi-target-directed ligands for Alzheimer's disease |
1.01 |
Eur. j. med. chem. |
2016 |
WoS |
55 |
|
|
|
|
13 |
6 |
13 |
12 |
5 |
6 |
|
Scopus |
61 |
|
|
|
|
13 |
7 |
15 |
11 |
6 |
7 |
2 |
43. |
4547697 |
Multi-target-directed ligands for treating Alzheimer's disease |
1.01 |
Eur. j. med. chem. |
2018 |
WoS |
56 |
|
|
|
|
|
1 |
17 |
14 |
12 |
12 |
|
Scopus |
60 |
|
|
|
|
|
1 |
17 |
14 |
13 |
12 |
3 |
44. |
4145265 |
Discovery of benzothiazole scaffold-based DNA gyrase B inhibitors |
1.01 |
J. med. chem. |
2016 |
WoS |
58 |
|
|
|
|
2 |
7 |
12 |
15 |
12 |
10 |
|
Scopus |
59 |
|
|
|
|
2 |
7 |
12 |
16 |
10 |
12 |
0 |
45. |
3408497 |
Bioactivation of bisphenol A and its analogs (BPF, BPAF, BPZ and DMBPA) in human liver
microsomes |
1.01 |
Toxicol. in vitro |
2013 |
WoS |
52 |
1 |
3 |
4 |
6 |
4 |
7 |
3 |
5 |
11 |
8 |
|
Scopus |
59 |
1 |
3 |
4 |
8 |
4 |
7 |
3 |
5 |
11 |
11 |
2 |
46. |
24845827 |
Natural sources, pharmacokinetics, biological activities and health benefits of hydroxycinnamic
acids and their metabolites |
1.02 |
Nutrients |
2020 |
WoS |
51 |
|
|
|
|
|
|
|
1 |
14 |
33 |
3 |
Scopus |
59 |
|
|
|
|
|
|
|
2 |
17 |
37 |
3 |
47. |
1536240835 |
Ru [sup] II, Os [sup] II, and Ir [sup] III complexes with chelating pyridyl-mesoionic
carbene ligands |
1.01 |
Chemistry |
2015 |
WoS |
54 |
|
|
4 |
11 |
10 |
10 |
3 |
5 |
8 |
3 |
|
Scopus |
56 |
|
|
4 |
10 |
10 |
10 |
4 |
5 |
9 |
4 |
|
48. |
3889009 |
Discovery of 4,5,6,7-tetrahydrobenzo[1,2-d]thiazoles as novel DNA gyrase inhibitors
targeting the ATP-binding site |
1.01 |
J. med. chem. |
2015 |
WoS |
54 |
|
|
0 |
4 |
3 |
6 |
10 |
14 |
12 |
5 |
0 |
Scopus |
56 |
|
|
1 |
3 |
4 |
8 |
10 |
14 |
11 |
5 |
0 |
49. |
1959793 |
Inhibitors of Cathepsin B |
1.01 |
Curr. med. chem. |
2006 |
WoS |
54 |
5 |
11 |
4 |
6 |
1 |
5 |
5 |
7 |
5 |
5 |
|
Scopus |
55 |
5 |
12 |
6 |
6 |
2 |
4 |
5 |
7 |
5 |
3 |
|
50. |
1708335 |
Exploring the scope of pyridyl- and picolyl-functionalized 1,2,3-triazol-5-ylidenes
in bidentate coordination to ruthenium(II) cymene chloride complexes |
1.01 |
Organometallics |
2014 |
WoS |
54 |
|
1 |
10 |
9 |
12 |
5 |
7 |
4 |
4 |
2 |
|
Scopus |
55 |
|
1 |
10 |
9 |
12 |
5 |
7 |
4 |
5 |
2 |
|
51. |
4085105 |
Influence of metabolism on endocrine activities of bisphenol S |
1.01 |
Chemosphere |
2016 |
WoS |
53 |
|
|
|
0 |
2 |
15 |
9 |
9 |
8 |
10 |
|
Scopus |
55 |
|
|
|
0 |
2 |
15 |
10 |
8 |
9 |
9 |
2 |
52. |
1688433 |
Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions
prepared by hot melt method |
1.01 |
Int. j. pharm. |
2005 |
WoS |
38 |
4 |
6 |
6 |
5 |
4 |
1 |
4 |
3 |
3 |
2 |
|
Scopus |
55 |
10 |
7 |
8 |
5 |
7 |
1 |
5 |
5 |
4 |
3 |
|
53. |
4768625 |
Development and optimization of liquid chromatography analytical methods by using
AQbD principles |
1.02 |
Org. process res. dev. |
2019 |
WoS |
53 |
|
|
|
|
|
|
|
2 |
22 |
28 |
1 |
Scopus |
54 |
|
|
|
|
|
|
|
2 |
24 |
26 |
2 |
54. |
38347267 |
Will morphing boron-based inhibitors beat the ß-lactamases? |
1.02 |
Curr. opin. chem. biol. |
2019 |
WoS |
49 |
|
|
|
|
|
|
2 |
16 |
20 |
11 |
|
Scopus |
54 |
|
|
|
|
|
|
2 |
19 |
21 |
12 |
|
55. |
31019737 |
Antifungal activity of cinnamic acid derivatives involves inhibition of benzoate 4-hydroxylase
(CYP53) |
1.01 |
J Appl Microbiol |
2014 |
WoS |
47 |
|
2 |
2 |
4 |
4 |
4 |
6 |
4 |
7 |
14 |
|
Scopus |
52 |
|
2 |
2 |
4 |
4 |
5 |
5 |
5 |
10 |
15 |
|
56. |
4614001 |
A road map for prioritizing warheads for cysteine targeting covalent inhibitors |
1.01 |
Eur. j. med. chem. |
2018 |
WoS |
45 |
|
|
|
|
|
|
5 |
13 |
11 |
16 |
|
Scopus |
52 |
|
|
|
|
|
|
6 |
14 |
13 |
16 |
3 |
57. |
7524436 |
Electro-mediated gene transfer and expression are controlled by the life-time of DNA/membrane
complex formation |
1.01 |
J. gene med. |
2010 |
WoS |
40 |
6 |
6 |
8 |
2 |
4 |
3 |
2 |
2 |
4 |
3 |
|
Scopus |
52 |
7 |
8 |
8 |
3 |
11 |
4 |
2 |
2 |
4 |
3 |
|
58. |
35127299 |
The impact of COVID-19 on the cancer care of adolescents and young adults and their
well-being: Results from an online survey conducted in the early stages of the pandemic |
1.01 |
Cancer |
2020 |
WoS |
51 |
|
|
|
|
|
|
|
4 |
24 |
23 |
|
Scopus |
51 |
|
|
|
|
|
|
|
5 |
23 |
23 |
|
59. |
3225201 |
Car-parrinello simulation of the vibrational spectrum of a medium strong hydrogen
bond by two-dimensional quantization of the nuclear motion: application to 2-hydroxy-5-ntrobenzamide |
1.01 |
J. phys. chem., B Mater. surf. interfaces biophys. |
2012 |
WoS |
50 |
5 |
6 |
3 |
9 |
7 |
8 |
5 |
4 |
1 |
2 |
|
Scopus |
51 |
5 |
6 |
4 |
9 |
7 |
8 |
5 |
4 |
1 |
2 |
|
60. |
6451540 |
The temperature effect during pulse application on cell membrane fluidity and permeabilization |
1.08 |
Bioelectrochemistry |
2008 |
WoS |
49 |
1 |
5 |
3 |
7 |
6 |
3 |
2 |
4 |
9 |
9 |
|
Scopus |
51 |
1 |
5 |
3 |
8 |
8 |
3 |
2 |
3 |
10 |
8 |
|
61. |
1429084 |
Historic overview and recent advances in the synthesis of super-statins |
1.02 |
Curr. org. chem. |
2010 |
WoS |
48 |
3 |
8 |
10 |
4 |
4 |
6 |
4 |
3 |
4 |
2 |
|
Scopus |
51 |
3 |
8 |
11 |
5 |
4 |
7 |
3 |
3 |
3 |
4 |
|
62. |
3794801 |
Design, synthesis and evaluation of new thiadiazole- based direct inhibitors of enoyl
acyl carrier protein reductase (InhA) for the treatment of tuberculosis |
1.01 |
J. med. chem. |
2015 |
WoS |
47 |
|
|
2 |
10 |
8 |
7 |
6 |
9 |
3 |
2 |
|
Scopus |
51 |
|
|
2 |
11 |
9 |
7 |
5 |
10 |
4 |
3 |
|
63. |
5901082 |
Stereoarrayed CF [sub] 3-substituted 1,3-diols by dynamic kinetic resolution |
1.01 |
Angew. Chem. |
2016 |
WoS |
43 |
|
|
|
4 |
3 |
10 |
7 |
6 |
8 |
5 |
|
Scopus |
51 |
|
|
|
4 |
3 |
9 |
8 |
6 |
12 |
8 |
1 |
64. |
4602737 |
Design and development of Nrf2 modulators for cancer chemoprevention and therapy |
1.02 |
Drug des. dev. ther. |
2018 |
WoS |
49 |
|
|
|
|
|
|
7 |
14 |
17 |
10 |
1 |
Scopus |
48 |
|
|
|
|
|
|
8 |
13 |
16 |
10 |
1 |
65. |
2357361 |
Recent advances in the synthesis of 1,2,4- and 1,3,4 oxadiazoles |
1.02 |
Curr. org. chem. |
2008 |
WoS |
48 |
5 |
6 |
8 |
6 |
6 |
2 |
3 |
4 |
2 |
6 |
|
Scopus |
49 |
5 |
6 |
8 |
7 |
6 |
2 |
3 |
4 |
3 |
5 |
|
66. |
4889969 |
Systematic exploration of different E3 ubiquitin ligases |
1.01 |
Chem. sci. |
2020 |
WoS |
47 |
|
|
|
|
|
|
|
4 |
18 |
23 |
2 |
Scopus |
49 |
|
|
|
|
|
|
|
4 |
15 |
28 |
2 |
67. |
2958449 |
Role of cyclic tertiary amine bioactivation to reactive iminium species: structure
toxicity relationship |
1.02 |
Current drug metabolism |
2011 |
WoS |
46 |
|
5 |
1 |
1 |
5 |
13 |
7 |
9 |
3 |
2 |
|
Scopus |
49 |
|
6 |
1 |
1 |
5 |
13 |
7 |
9 |
4 |
3 |
|
68. |
1525340 |
Basic CuCO3/ligand as a new catalyst for 'on water' borylation of Michael acceptors,
alkenes and alkynes: application to the efficient asymmetric synthesis of alpha-alcohol
type sitagliptin side chain |
1.01 |
Appl. organomet. chem. |
2013 |
WoS |
47 |
3 |
6 |
7 |
11 |
3 |
4 |
3 |
1 |
5 |
4 |
|
Scopus |
47 |
3 |
6 |
7 |
10 |
3 |
4 |
3 |
1 |
6 |
4 |
|
69. |
958833 |
Arginine mimetics |
1.02 |
Tetrahedron |
2001 |
WoS |
44 |
5 |
9 |
10 |
3 |
5 |
5 |
2 |
1 |
3 |
1 |
|
Scopus |
47 |
7 |
10 |
10 |
3 |
5 |
5 |
2 |
1 |
3 |
1 |
|
70. |
4868465 |
Cannabinoid content in industrial hemp (Cannabis sativa L.) varieties grown in Slovenia |
1.01 |
Ind. crops prod. |
2020 |
WoS |
42 |
|
|
|
|
|
|
|
6 |
17 |
18 |
1 |
Scopus |
47 |
|
|
|
|
|
|
|
6 |
19 |
20 |
2 |
71. |
1245809 |
Abuse of clenbuterol and its detection |
1.01 |
Curr. med. chem. |
2003 |
WoS |
45 |
11 |
4 |
1 |
6 |
5 |
2 |
5 |
4 |
4 |
2 |
1 |
Scopus |
46 |
10 |
4 |
2 |
5 |
6 |
3 |
5 |
4 |
4 |
2 |
1 |
72. |
1537031875 |
Ru [sup] II, Ir [sup] III and Os [sup] II mesoionic carbene complexes |
1.01 |
Dalton trans. |
2016 |
WoS |
43 |
|
|
|
2 |
8 |
8 |
4 |
9 |
9 |
3 |
|
Scopus |
46 |
|
|
|
3 |
8 |
8 |
4 |
10 |
10 |
3 |
|
73. |
2731377 |
In silico discovery of 2-amino-4-(2,4-dihydroxyphenyl)thiazoles as novel inhibitors
of DNA gyrase B |
1.01 |
Bioorg. med. chem. lett. |
2010 |
WoS |
40 |
7 |
4 |
6 |
3 |
1 |
5 |
1 |
7 |
4 |
2 |
|
Scopus |
46 |
9 |
4 |
7 |
5 |
1 |
6 |
2 |
6 |
3 |
3 |
|
74. |
6679380 |
Mechanisms involved in gene electrotransfer using high- and low-voltage pulses - an
in vitro study |
1.01 |
Bioelectrochemistry |
2009 |
WoS |
40 |
10 |
8 |
2 |
2 |
2 |
3 |
1 |
2 |
6 |
4 |
|
Scopus |
46 |
10 |
8 |
2 |
2 |
4 |
3 |
0 |
5 |
8 |
4 |
|
75. |
4363633 |
Antibacterial and beta-lactamase inhibitory activity of monocyclic beta-lactams |
1.02 |
Med. res. rev. |
2018 |
WoS |
44 |
|
|
|
|
1 |
4 |
7 |
12 |
10 |
10 |
|
Scopus |
45 |
|
|
|
|
2 |
3 |
6 |
12 |
10 |
11 |
1 |
76. |
2752113 |
Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones |
1.01 |
Eur. j. med. chem. |
2010 |
WoS |
43 |
3 |
7 |
4 |
2 |
5 |
3 |
6 |
5 |
4 |
4 |
|
Scopus |
45 |
3 |
7 |
5 |
4 |
5 |
4 |
3 |
7 |
3 |
4 |
|
77. |
3893361 |
LiSiCA |
1.01 |
J. chem. inf. mod. |
2015 |
WoS |
41 |
|
|
|
3 |
3 |
2 |
10 |
7 |
5 |
11 |
|
Scopus |
45 |
|
|
|
3 |
2 |
3 |
10 |
7 |
8 |
12 |
|
78. |
3579761 |
Prospects for developing new antibacterials targeting bacterial type IIa topoisomerases |
1.02 |
Curr. topics med. chem. |
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Scopus |
45 |
|
4 |
5 |
5 |
5 |
8 |
3 |
7 |
2 |
6 |
0 |
79. |
4217457 |
Chemical profile, antioxidant activity and stability in stimulated gastrointestinal
tract model system of three Verbascum species |
1.01 |
Ind. crops prod. |
2016 |
WoS |
44 |
|
|
|
|
2 |
5 |
10 |
15 |
7 |
5 |
|
Scopus |
44 |
|
|
|
|
2 |
4 |
9 |
15 |
7 |
7 |
|
80. |
3806577 |
Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as
cholinesterase and ß-amyloid aggregation inhibitors with neuroprotective properties |
1.01 |
Eur. j. med. chem. |
2015 |
WoS |
43 |
|
|
2 |
5 |
8 |
6 |
8 |
7 |
3 |
4 |
|
Scopus |
44 |
|
|
1 |
5 |
10 |
6 |
7 |
9 |
2 |
4 |
|
81. |
1536664003 |
A mesoionic bis(Py-tzNHC) palladium(II) complex catalyses "green" Sonogashira reaction
through an unprecedented mechanism |
1.01 |
Chem. commun. |
2016 |
WoS |
44 |
|
|
|
4 |
9 |
6 |
7 |
7 |
6 |
5 |
|
Scopus |
43 |
|
|
|
4 |
9 |
8 |
5 |
7 |
5 |
5 |
|
82. |
1694065 |
Azapeptides as pharmacological agents |
1.01 |
Curr. med. chem. |
2005 |
WoS |
44 |
4 |
6 |
5 |
4 |
6 |
6 |
3 |
4 |
3 |
3 |
|
Scopus |
43 |
4 |
6 |
5 |
4 |
6 |
7 |
2 |
4 |
3 |
2 |
|
83. |
4747121 |
Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium
antibacterial agents |
1.01 |
Eur. j. med. chem. |
2019 |
WoS |
41 |
|
|
|
|
|
|
5 |
12 |
13 |
11 |
|
Scopus |
44 |
|
|
|
|
|
|
5 |
11 |
14 |
13 |
1 |
84. |
2743921 |
5-benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases |
1.01 |
ChemMedChem |
2010 |
WoS |
39 |
2 |
6 |
1 |
2 |
5 |
4 |
10 |
3 |
3 |
3 |
|
Scopus |
44 |
2 |
6 |
1 |
1 |
6 |
6 |
7 |
5 |
4 |
6 |
|
85. |
1623855 |
A selective approach to pyridine appended 1,2,3-triazolium salts |
1.01 |
Org. lett. |
2013 |
WoS |
43 |
|
5 |
5 |
6 |
7 |
8 |
2 |
1 |
5 |
4 |
|
Scopus |
43 |
|
5 |
5 |
6 |
7 |
8 |
2 |
1 |
5 |
4 |
|
86. |
3024241 |
Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds |
1.01 |
ChemMedChem |
2011 |
WoS |
42 |
0 |
4 |
4 |
6 |
2 |
5 |
4 |
9 |
4 |
4 |
|
Scopus |
43 |
0 |
4 |
5 |
6 |
2 |
5 |
3 |
9 |
4 |
4 |
1 |
87. |
3629169 |
Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F |
1.02 |
Bioorg. chem. |
2014 |
WoS |
38 |
|
1 |
|
2 |
4 |
5 |
6 |
9 |
3 |
7 |
1 |
Scopus |
42 |
|
1 |
|
2 |
4 |
5 |
6 |
11 |
3 |
9 |
1 |
88. |
3134799 |
Estrogenic and androgenic activities of TBBA and TBMEPH, metabolites of novel brominated
flame retardants, and selected bisphenols, using the XenoScreen XL YES/YAS assay |
1.01 |
Chemosphere |
2014 |
WoS |
40 |
|
|
1 |
5 |
2 |
3 |
9 |
7 |
4 |
9 |
|
Scopus |
41 |
|
|
1 |
5 |
2 |
3 |
9 |
7 |
5 |
9 |
|
89. |
5312596 |
Cell membrane fluidity related to electroporation and resealing |
1.01 |
Eur. biophys. j. |
2006 |
WoS |
38 |
1 |
3 |
5 |
2 |
3 |
7 |
3 |
6 |
7 |
1 |
|
Scopus |
41 |
1 |
4 |
3 |
3 |
5 |
6 |
2 |
8 |
5 |
3 |
1 |
90. |
3730312 |
Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and
Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with
irritable bowel syndrome |
1.01 |
J. dairy sci. |
2016 |
WoS |
36 |
|
|
|
1 |
2 |
5 |
6 |
7 |
12 |
3 |
|
Scopus |
41 |
|
|
|
2 |
3 |
5 |
7 |
8 |
14 |
2 |
|
91. |
3508081 |
The effect of lipid composition and liposome size on the release properties of liposomes-in-hydrogel |
1.01 |
Int. j. pharm. |
2013 |
WoS |
39 |
|
2 |
7 |
5 |
7 |
2 |
2 |
6 |
3 |
5 |
|
Scopus |
40 |
|
2 |
7 |
5 |
7 |
2 |
3 |
6 |
3 |
5 |
|
92. |
1565020 |
CuII and Cu0 catalyzed mono borylation of unsaturated hydrocarbons with B2pin2: entering
into the water |
1.02 |
ChemCatChem |
2014 |
WoS |
40 |
|
|
4 |
6 |
5 |
7 |
4 |
3 |
9 |
2 |
|
Scopus |
39 |
|
|
4 |
6 |
5 |
6 |
4 |
3 |
9 |
2 |
|
93. |
4644465 |
Chemicals and drugs forming reactive quinone and quinone imine metabolites |
1.02 |
Chem. res. toxicol. |
2019 |
WoS |
38 |
|
|
|
|
|
|
1 |
15 |
9 |
12 |
1 |
Scopus |
40 |
|
|
|
|
|
|
|
16 |
12 |
11 |
1 |
94. |
4571505 |
Antimicrobial activity of trans-cinnamic acid and commonly used antibiotics against
important fish pathogens and non-pathogenic isolates |
1.01 |
J Appl Microbiol |
2018 |
WoS |
38 |
|
|
|
|
|
|
9 |
5 |
12 |
10 |
2 |
Scopus |
40 |
|
|
|
|
|
|
8 |
6 |
13 |
10 |
3 |
95. |
27732441 |
Synthesis and biological evaluation of (6- and 7-phenyl) coumarin derivatives as selective
nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 |
1.01 |
J. med. chem. |
2011 |
WoS |
36 |
3 |
7 |
1 |
3 |
2 |
4 |
2 |
5 |
4 |
5 |
|
Scopus |
40 |
3 |
8 |
1 |
4 |
4 |
4 |
1 |
5 |
5 |
4 |
1 |
96. |
9419604 |
Combination of microsecond and nanosecond pulsed electric field treatments for inactivation
of Escherichia coli in water samples |
1.08 |
J. membr. biol. |
2012 |
WoS |
31 |
1 |
5 |
4 |
3 |
3 |
5 |
1 |
5 |
3 |
1 |
|
Scopus |
40 |
2 |
5 |
4 |
4 |
3 |
8 |
2 |
7 |
3 |
2 |
|
97. |
2109041 |
Recent advances in the synthesis of unnatural [alpha]-amino acids |
1.01 |
Curr. org. chem. |
2007 |
WoS |
39 |
3 |
4 |
5 |
6 |
4 |
3 |
4 |
4 |
3 |
3 |
|
Scopus |
38 |
3 |
4 |
4 |
6 |
4 |
3 |
4 |
5 |
2 |
3 |
|
98. |
1538148547 |
Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's
disease |
1.01 |
Chem. commun. |
2019 |
WoS |
38 |
|
|
|
|
|
|
6 |
7 |
9 |
16 |
|
Scopus |
39 |
|
|
|
|
|
|
5 |
8 |
10 |
16 |
0 |
99. |
3833713 |
Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with
ß-amyloid anti-aggregation properties and beneficial effects on memory in vivo |
1.01 |
Bioorg. med. chem. |
2015 |
WoS |
37 |
|
|
|
4 |
6 |
6 |
5 |
8 |
4 |
3 |
1 |
Scopus |
39 |
|
|
1 |
4 |
6 |
6 |
7 |
8 |
4 |
2 |
1 |
100. |
4444273 |
Inhibition of D-Ala |
1.01 |
Nature communications |
2017 |
WoS |
37 |
|
|
|
|
|
|
8 |
9 |
11 |
9 |
0 |
Scopus |
39 |
|
|
|
|
|
|
7 |
11 |
11 |
10 |
0 |
101. |
4329841 |
Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease |
1.02 |
Future medicinal chemistry |
2017 |
WoS |
39 |
|
|
|
|
1 |
4 |
11 |
9 |
8 |
5 |
1 |
Scopus |
36 |
|
|
|
|
|
3 |
10 |
9 |
10 |
2 |
2 |
102. |
3697521 |
Screening of bisphenol A, triclosan and paraben analogues as modulators of the glucocorticoid
and androgen receptor activities |
1.01 |
Toxicol. in vitro |
2015 |
WoS |
35 |
|
|
1 |
1 |
4 |
5 |
8 |
6 |
4 |
6 |
|
Scopus |
39 |
|
|
2 |
2 |
5 |
5 |
8 |
6 |
5 |
6 |
|
103. |
4248177 |
N-propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2- sulfonamide
moieties |
1.01 |
Bioorg. med. chem. |
2017 |
WoS |
35 |
|
|
|
|
4 |
3 |
10 |
9 |
6 |
2 |
1 |
Scopus |
39 |
|
|
|
|
5 |
5 |
9 |
8 |
7 |
2 |
3 |
104. |
3441009 |
Melanin is crucial for growth of the black yeast Hortaea werneckii in its natural
hypersaline environment |
1.01 |
Fungal biology |
2013 |
WoS |
35 |
1 |
2 |
1 |
3 |
3 |
2 |
|
5 |
7 |
11 |
|
Scopus |
39 |
1 |
2 |
1 |
3 |
2 |
2 |
|
8 |
7 |
12 |
1 |
105. |
3914865 |
Antioxidant and anti-inflammatory properties of 1,2,4-oxadiazole analogs of resveratrol |
1.01 |
Chem.-biol. interact. |
2015 |
WoS |
32 |
|
|
|
3 |
5 |
7 |
4 |
2 |
3 |
8 |
|
Scopus |
39 |
|
|
|
4 |
5 |
7 |
4 |
2 |
6 |
10 |
1 |
106. |
3370865 |
Development of new cathepsin B inhibitors: combining bioisosteric replacements and
structure-based design to explore the structure-activity relationships of nitroxoline
derivatives |
1.01 |
J. med. chem. |
2013 |
WoS |
38 |
2 |
3 |
4 |
7 |
1 |
6 |
5 |
2 |
4 |
4 |
|
Scopus |
37 |
2 |
3 |
4 |
6 |
1 |
6 |
5 |
2 |
4 |
4 |
|
107. |
2881905 |
Fluconazole cocrystals with dicarboxylic acids |
1.01 |
Cryst. growth des. |
2010 |
WoS |
37 |
7 |
6 |
|
1 |
3 |
2 |
5 |
2 |
8 |
3 |
|
Scopus |
38 |
7 |
6 |
|
1 |
4 |
2 |
6 |
2 |
8 |
2 |
|
108. |
3019121 |
Structure-based design of a new series of D-Glutamic acid-based inhibitors of bacterial
UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD) |
1.01 |
J. med. chem. |
2011 |
WoS |
36 |
2 |
2 |
4 |
5 |
5 |
4 |
8 |
2 |
1 |
3 |
|
Scopus |
38 |
2 |
2 |
4 |
3 |
6 |
5 |
8 |
2 |
1 |
5 |
|
109. |
1531740 |
A highly productive, whole-cell DERA chemoenzymatic process for production of key
lactonized side-chain intermediates in statin synthesis |
1.01 |
PloS one |
2013 |
WoS |
35 |
|
1 |
9 |
1 |
4 |
5 |
4 |
5 |
3 |
3 |
|
Scopus |
38 |
|
2 |
10 |
2 |
4 |
6 |
3 |
5 |
4 |
2 |
|
110. |
3849841 |
Genome-wide gene expression profiling of low-dose, long-term exposure of human osteosarcoma
cells to bisphenol A and its analogs bisphenols AF and S |
1.01 |
Toxicol. in vitro |
2015 |
WoS |
34 |
|
|
|
2 |
5 |
9 |
5 |
4 |
8 |
|
1 |
Scopus |
38 |
|
|
|
3 |
6 |
11 |
5 |
4 |
7 |
1 |
1 |
111. |
4168305 |
A new 'golden age' for the antitubercular target InhA |
1.02 |
Drug discov. today |
2017 |
WoS |
33 |
|
|
|
|
1 |
5 |
6 |
8 |
7 |
6 |
|
Scopus |
38 |
|
|
|
|
1 |
6 |
7 |
8 |
8 |
8 |
|
112. |
4130673 |
Identification of novel chemical scaffolds inhibiting trypanothione synthetase from
pathogenic trypanosomatids |
1.01 |
PLoS negl. trop. dis. |
2016 |
WoS |
32 |
|
|
|
1 |
5 |
5 |
4 |
7 |
4 |
6 |
|
Scopus |
38 |
|
|
|
|
5 |
9 |
3 |
8 |
4 |
8 |
1 |
113. |
4284017 |
Determination of fagopyrins, rutin, and quercetin in Tartary buckwheat products |
1.01 |
Lebensm.-Wiss. + Technol. |
2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Scopus |
38 |
|
|
|
1 |
1 |
3 |
9 |
6 |
8 |
10 |
|
114. |
14485287 |
A double-edged kinase lyn |
1.01 |
J. exp. med. |
1998 |
WoS |
37 |
8 |
4 |
3 |
7 |
1 |
3 |
1 |
2 |
4 |
4 |
|
Scopus |
37 |
9 |
5 |
4 |
5 |
1 |
3 |
1 |
1 |
4 |
4 |
|
115. |
3874161 |
Structure-based development of nitroxoline derivatives as potential multifunctional
anti-Alzheimer agents |
1.01 |
Bioorg. med. chem. |
2015 |
WoS |
35 |
|
|
|
5 |
7 |
4 |
7 |
3 |
3 |
5 |
1 |
Scopus |
37 |
|
|
|
5 |
7 |
5 |
7 |
3 |
3 |
6 |
1 |
116. |
4758897 |
Pharmacogenomics education in medical and pharmacy schools |
1.01 |
Pharmacogenomics |
2019 |
WoS |
37 |
|
|
|
|
|
|
|
8 |
20 |
9 |
|
Scopus |
35 |
|
|
|
|
|
|
2 |
3 |
23 |
7 |
|
117. |
3107953 |
New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis,
crystal structures, and biological evaluation |
1.01 |
Eur. j. med. chem. |
2011 |
WoS |
35 |
3 |
7 |
2 |
3 |
4 |
1 |
5 |
4 |
3 |
3 |
|
Scopus |
37 |
3 |
7 |
2 |
1 |
4 |
2 |
5 |
4 |
4 |
5 |
|
118. |
75626755 |
E3 ligase ligands in successful PROTACs |
1.02 |
Front. chem. |
2021 |
WoS |
33 |
|
|
|
|
|
|
|
|
3 |
29 |
1 |
Scopus |
37 |
|
|
|
|
|
|
|
|
4 |
30 |
3 |
119. |
3816561 |
Isoindoline-1,3-dione derivatives targeting cholinesterases |
1.01 |
Bioorg. med. chem. |
2015 |
WoS |
32 |
|
|
1 |
5 |
2 |
4 |
9 |
5 |
4 |
2 |
|
Scopus |
37 |
|
|
2 |
5 |
2 |
4 |
11 |
7 |
3 |
2 |
1 |
120. |
2371697 |
3,4-Dihydro-2H-1,4-benzoxazine derivatives combining thrombin inhibitory and glycoprotein
IIb/IIIa receptor antagonistic activity as a novel class of antithrombotic compounds
with dual function |
1.01 |
J. med. chem. |
2008 |
WoS |
31 |
2 |
3 |
7 |
3 |
8 |
|
1 |
1 |
5 |
1 |
|
Scopus |
37 |
2 |
3 |
7 |
4 |
8 |
3 |
1 |
2 |
4 |
3 |
|
121. |
4507249 |
Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular
and renal protection. |
1.02 |
Med. res. rev. |
2019 |
WoS |
36 |
|
|
|
|
|
|
3 |
7 |
13 |
13 |
|
Scopus |
36 |
|
|
|
|
|
|
2 |
8 |
12 |
14 |
|
122. |
4132209 |
Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in
stem cell homing and myocardial repair |
1.01 |
Pharmacol. ther. |
2016 |
WoS |
36 |
|
|
|
|
3 |
7 |
6 |
7 |
10 |
3 |
|
Scopus |
33 |
|
|
|
|
3 |
7 |
4 |
8 |
9 |
2 |
|
123. |
3701274 |
Structural and functional characterization of enantiomeric glutamic acid derivatives
as potential transition state analogue inhibitors of MurD ligase |
1.01 |
J. mol. biol. |
2007 |
WoS |
33 |
3 |
3 |
3 |
0 |
4 |
1 |
6 |
3 |
7 |
3 |
|
Scopus |
36 |
3 |
3 |
3 |
0 |
5 |
1 |
5 |
4 |
8 |
4 |
|
124. |
3274865 |
Dual inhibitor of MurD and MurE ligases from Escherichia coli and Staphylococcus aureus |
1.01 |
ACS Medicinal Chemistry Letters |
2012 |
WoS |
32 |
1 |
3 |
0 |
1 |
6 |
2 |
7 |
6 |
4 |
2 |
|
Scopus |
36 |
1 |
3 |
1 |
0 |
7 |
3 |
5 |
7 |
5 |
4 |
|
125. |
25801689 |
Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide
(A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis |
1.01 |
Drug metab. dispos. |
2009 |
WoS |
31 |
4 |
4 |
5 |
3 |
3 |
3 |
3 |
1 |
4 |
1 |
|
Scopus |
36 |
3 |
6 |
6 |
3 |
3 |
3 |
3 |
1 |
5 |
3 |
|
126. |
6812500 |
Electroporation in biological cell and tissue |
1.16 |
Electrotechnologies for extraction from food plants and biomaterials |
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Scopus |
36 |
1 |
3 |
2 |
7 |
3 |
2 |
4 |
5 |
4 |
3 |
2 |
127. |
4336241 |
Synthesis and structure-activity relationship study of novel quinazolinone-based inhibitors
of MurA |
1.01 |
Bioorg. med. chem. lett. |
2017 |
WoS |
32 |
|
|
|
|
|
7 |
9 |
7 |
5 |
4 |
|
Scopus |
35 |
|
|
|
|
|
7 |
9 |
8 |
5 |
6 |
|
128. |
4465009 |
Design, synthesis and biological evaluation of 1-benzylamino-2-hydroxyalkyl derivatives
as new potential disease-modifying multifunctional anti-Alzheimer's agents |
1.01 |
ACS chem. neurosci. |
2018 |
WoS |
32 |
|
|
|
|
|
1 |
14 |
5 |
8 |
4 |
|
Scopus |
34 |
|
|
|
|
|
1 |
15 |
4 |
9 |
4 |
1 |
129. |
4033137 |
In vitro impact of bisphenols BPA, BPF, BPAF and 17ß estradiol (E2) on human monocyte-derived
dendritic cell generation, maturation and function |
1.01 |
International immunopharmacology |
2016 |
WoS |
31 |
|
|
|
2 |
5 |
4 |
4 |
5 |
5 |
5 |
1 |
Scopus |
34 |
|
|
|
2 |
5 |
5 |
3 |
7 |
4 |
7 |
1 |
130. |
3836017 |
Xanthine oxidase inhibitory properties and anti-inflammatory activity of 2-amino-5-alkylidene-thiazol-4-ones |
1.01 |
Chem.-biol. interact. |
2015 |
WoS |
31 |
|
|
2 |
3 |
7 |
5 |
2 |
3 |
3 |
6 |
|
Scopus |
34 |
|
|
2 |
3 |
7 |
5 |
2 |
4 |
3 |
8 |
|
131. |
1518428 |
Application of flow photochemical bromination in the synthesis of a 5-bromomethylpyrimidine
precursor of rosuvastatin: improvement of productivityand product purity |
1.01 |
Org. process res. dev. |
2013 |
WoS |
30 |
1 |
6 |
3 |
6 |
1 |
4 |
2 |
2 |
3 |
2 |
|
Scopus |
34 |
1 |
6 |
4 |
6 |
2 |
4 |
2 |
4 |
4 |
1 |
|
132. |
4292465 |
Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors |
1.01 |
Eur. j. med. chem. |
2017 |
WoS |
30 |
|
|
|
|
1 |
3 |
4 |
8 |
9 |
5 |
|
Scopus |
33 |
|
|
|
|
1 |
4 |
5 |
8 |
10 |
5 |
|
133. |
4470641 |
Novel multi-target-directed ligands aiming at symptoms and causes of Alzheimer's disease |
1.01 |
ACS chem. neurosci. |
2018 |
WoS |
28 |
|
|
|
|
|
1 |
14 |
7 |
2 |
4 |
|
Scopus |
33 |
|
|
|
|
|
1 |
17 |
6 |
2 |
6 |
1 |
134. |
3346033 |
Lactic acid bacteria as oral delivery systems for biomolecules |
1.01 |
Pharmazie |
2012 |
WoS |
26 |
1 |
1 |
1 |
6 |
4 |
6 |
1 |
4 |
1 |
1 |
|
Scopus |
33 |
1 |
2 |
2 |
6 |
5 |
6 |
2 |
4 |
3 |
2 |
|
135. |
1509980 |
Recent advances in the retro-claisen reaction and its synthetic applications |
1.02 |
Current organic synthesis |
2012 |
WoS |
32 |
3 |
5 |
1 |
2 |
2 |
4 |
4 |
5 |
3 |
3 |
|
Scopus |
32 |
3 |
5 |
1 |
2 |
2 |
4 |
4 |
4 |
3 |
4 |
|
136. |
3452785 |
Structure-activity relationships of new cyanothiophene inhibitors of the essential
peptidoglycan biosynthesis enzyme MurF |
1.01 |
Eur. j. med. chem. |
2013 |
WoS |
31 |
|
5 |
|
2 |
5 |
|
5 |
5 |
3 |
6 |
|
Scopus |
32 |
|
5 |
|
2 |
5 |
|
3 |
7 |
3 |
7 |
|
137. |
3834225 |
Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin
B activity |
1.01 |
Oncotarget |
2015 |
WoS |
32 |
|
|
|
4 |
2 |
4 |
6 |
8 |
4 |
4 |
|
Scopus |
31 |
|
|
0 |
4 |
2 |
4 |
6 |
7 |
5 |
3 |
|
138. |
4060698 |
Novel naphthalene-N-sulfonyl-d-glutamic acid derivatives as inhibitors of MurD, a
key peptidoglycan biosynthesis enzyme |
1.01 |
J. med. chem. |
2008 |
WoS |
30 |
4 |
3 |
|
3 |
2 |
1 |
7 |
4 |
4 |
2 |
|
Scopus |
32 |
4 |
2 |
2 |
1 |
3 |
1 |
6 |
5 |
5 |
3 |
|
139. |
4366193 |
Structure-activity relationships and molecular docking studies of chromene and chromene
based azo chromophores |
1.01 |
EXCLI j. |
2017 |
WoS |
29 |
|
|
|
|
|
1 |
10 |
4 |
7 |
7 |
|
Scopus |
32 |
|
|
|
|
|
1 |
10 |
5 |
8 |
7 |
1 |
140. |
2744177 |
Advances in the chemistry of saccharins |
1.02 |
Curr. med. chem. |
2010 |
WoS |
31 |
4 |
1 |
2 |
3 |
5 |
4 |
4 |
6 |
1 |
1 |
|
Scopus |
31 |
4 |
1 |
2 |
3 |
5 |
4 |
4 |
5 |
2 |
1 |
|
141. |
3160945 |
Reactivity of bisphenol A-3,4-quinone with DNA. A quantum chemical study |
1.01 |
Toxicol. in vitro |
2012 |
WoS |
28 |
2 |
6 |
3 |
2 |
1 |
3 |
2 |
5 |
2 |
2 |
|
Scopus |
31 |
2 |
6 |
3 |
2 |
1 |
4 |
2 |
5 |
2 |
4 |
|
142. |
3194737 |
DC-SIGN antagonists, a potential new class of anti-infectives |
1.02 |
Curr. med. chem. |
2012 |
WoS |
27 |
5 |
4 |
2 |
3 |
4 |
1 |
2 |
1 |
3 |
2 |
|
Scopus |
31 |
8 |
4 |
4 |
3 |
3 |
1 |
2 |
1 |
3 |
2 |
|
143. |
1536057283 |
Synthesis and NMR analysis of 1,4-disubstituted 1,2,3-triazoles tethered to pyridine,
pyrimidine, and pyrazine rings |
1.01 |
European journal of organic chemistry |
2014 |
WoS |
26 |
|
|
2 |
4 |
4 |
3 |
4 |
4 |
1 |
4 |
|
Scopus |
31 |
|
|
3 |
4 |
4 |
3 |
5 |
4 |
3 |
5 |
|
144. |
4387185 |
Accumulation of heavy metals from soil in medicinal plants |
1.01 |
Arh. hig. rada toksikol. |
2017 |
WoS |
22 |
|
|
|
|
|
1 |
1 |
6 |
10 |
4 |
|
Scopus |
31 |
|
|
|
|
|
1 |
2 |
8 |
12 |
7 |
1 |
145. |
3538289 |
Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based
virtual screening |
1.01 |
Eur. j. med. chem. |
2013 |
WoS |
30 |
|
1 |
6 |
5 |
3 |
1 |
4 |
3 |
3 |
3 |
1 |
Scopus |
30 |
|
1 |
6 |
5 |
3 |
1 |
4 |
4 |
2 |
3 |
1 |
146. |
11739732 |
Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable
MDA-MB-231 breast cancer cells in vitro |
1.01 |
Sci. rep. |
2017 |
WoS |
30 |
|
|
|
|
|
4 |
3 |
11 |
8 |
4 |
|
Scopus |
30 |
|
|
|
|
|
4 |
5 |
9 |
8 |
4 |
|
147. |
1896817 |
The application of freidinger lactams and their analogs in the design of conformationally
constrained peptidomimetics |
1.02 |
Curr. med. chem. |
2006 |
WoS |
30 |
5 |
5 |
3 |
2 |
2 |
5 |
2 |
4 |
2 |
|
|
Scopus |
30 |
5 |
5 |
3 |
2 |
1 |
5 |
3 |
4 |
2 |
|
|
148. |
4231793 |
Polymorphic variation in TPMT is the principal determinant of TPMT phenotype |
1.01 |
Clinical pharmacology & therapeutics |
2017 |
WoS |
29 |
|
|
|
|
2 |
4 |
9 |
4 |
6 |
3 |
1 |
Scopus |
30 |
|
|
|
|
2 |
5 |
9 |
4 |
7 |
3 |
|
149. |
1479004 |
Iridium-catalyzed chemoselective and enantioselective hydrogenation of (1-chloro-1-alkenyl)
boronic esters |
1.01 |
Angew. Chem. |
2012 |
WoS |
29 |
4 |
6 |
2 |
2 |
2 |
2 |
1 |
2 |
4 |
4 |
|
Scopus |
30 |
4 |
6 |
1 |
3 |
2 |
2 |
1 |
2 |
6 |
3 |
|
150. |
4218737 |
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic
functions |
1.01 |
eLife |
2016 |
WoS |
30 |
|
|
|
|
2 |
3 |
4 |
6 |
8 |
7 |
|
Scopus |
27 |
|
|
|
|
2 |
3 |
3 |
6 |
7 |
6 |
|
151. |
24820739 |
Escaping from Flatland |
1.02 |
Chemistry |
2021 |
WoS |
27 |
|
|
|
|
|
|
|
|
13 |
14 |
|
Scopus |
30 |
|
|
|
|
|
|
|
1 |
12 |
16 |
1 |
152. |
2360433 |
Synthesis of novel DC-SIGN ligands with an [alpha]-fucosylamide anchor |
1.01 |
ChemBioChem |
2008 |
WoS |
27 |
11 |
0 |
4 |
3 |
1 |
1 |
1 |
2 |
3 |
1 |
|
Scopus |
30 |
12 |
0 |
5 |
3 |
1 |
1 |
2 |
1 |
4 |
1 |
|
153. |
10952788 |
New insights into the mechanisms of gene electrotransfer - experimental and theoretical
analysis |
1.01 |
Sci. rep. |
2015 |
WoS |
27 |
|
|
0 |
3 |
5 |
2 |
4 |
5 |
4 |
4 |
|
Scopus |
30 |
|
|
|
4 |
5 |
4 |
3 |
6 |
4 |
4 |
|
154. |
3602801 |
Antimicrobial activity of the marine alkaloids, clathrodin and oroidin, and their
synthetic analogues |
1.01 |
Mar. drugs |
2014 |
WoS |
25 |
|
0 |
1 |
3 |
5 |
2 |
1 |
6 |
3 |
4 |
|
Scopus |
30 |
|
0 |
1 |
5 |
6 |
2 |
2 |
6 |
4 |
4 |
|
155. |
6387994 |
Stereoarrayed 2,3-disubstituted 1-indanols via ruthenium(II)-catalyzed dynamic kinetic
resolution-asymmetric transfer hydrogenation |
1.01 |
Org. lett. |
2018 |
WoS |
28 |
|
|
|
|
|
3 |
8 |
6 |
8 |
3 |
|
Scopus |
29 |
|
|
|
|
|
2 |
9 |
4 |
10 |
4 |
|
156. |
3557489 |
Chemical composition of the silver fir (Abies alba) bark extract Abigenol and its
antioxidant activity |
1.01 |
Ind. crops prod. |
2014 |
WoS |
28 |
|
|
0 |
0 |
1 |
3 |
7 |
3 |
3 |
10 |
1 |
Scopus |
29 |
|
|
0 |
0 |
1 |
3 |
7 |
3 |
4 |
10 |
1 |
157. |
2805617 |
Small molecule antagonists of integrin receptors |
1.01 |
Curr. med. chem. |
2010 |
WoS |
26 |
7 |
4 |
3 |
6 |
1 |
1 |
1 |
1 |
1 |
|
1 |
Scopus |
29 |
8 |
4 |
2 |
7 |
1 |
1 |
1 |
1 |
2 |
|
2 |
158. |
2964849 |
ATP-binding site of bacterial enzymes as a target for antibacterial drug design |
1.02 |
J. med. chem. |
2011 |
WoS |
26 |
4 |
8 |
1 |
2 |
3 |
1 |
4 |
2 |
1 |
|
|
Scopus |
29 |
5 |
6 |
2 |
2 |
3 |
2 |
4 |
3 |
1 |
1 |
0 |
159. |
2534001 |
Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and
MurE ligases by structure-based virtual screening approach |
1.01 |
Bioorg. med. chem. lett. |
2009 |
WoS |
24 |
3 |
2 |
0 |
1 |
4 |
1 |
5 |
5 |
1 |
2 |
|
Scopus |
29 |
3 |
3 |
1 |
1 |
6 |
1 |
5 |
5 |
2 |
2 |
|
160. |
4413297 |
Influence of different classes of crosslinkers on alginate polyelectrolyte nanoparticle
formation, thermodynamics and characteristics |
1.01 |
Carbohydr. polym. |
2018 |
WoS |
28 |
|
|
|
|
|
3 |
5 |
6 |
6 |
8 |
|
Scopus |
28 |
|
|
|
|
|
3 |
5 |
6 |
6 |
8 |
|
161. |
3835505 |
Differences in the glucuronidation of bisphenols F and S between two homologous human
UGT enzymes, 1A9 and 1A10 |
1.01 |
Xenobiotica |
2015 |
WoS |
26 |
|
|
|
1 |
3 |
4 |
5 |
4 |
5 |
4 |
|
Scopus |
28 |
|
|
|
1 |
5 |
5 |
5 |
4 |
5 |
3 |
|
162. |
2462321 |
Three-component one-pot synthetic route to 2-amino-5-alkylidenethiazol-4-ones |
1.01 |
Tetrahedron |
2009 |
WoS |
26 |
4 |
7 |
2 |
3 |
2 |
2 |
2 |
|
3 |
1 |
|
Scopus |
28 |
4 |
7 |
2 |
3 |
3 |
2 |
2 |
|
3 |
1 |
1 |
163. |
8213332 |
Cell counting tool parameters optimization approach for electroporation efficiency
determination of attached cells in phase contrast images |
1.01 |
J. Microsc. |
2011 |
WoS |
23 |
7 |
7 |
1 |
2 |
2 |
|
|
1 |
3 |
|
|
Scopus |
28 |
8 |
7 |
3 |
1 |
2 |
1 |
|
2 |
3 |
1 |
|
164. |
2245489 |
Shape optimization and characterization of polysaccharide beads prepared by ionotropic
gelation |
1.01 |
J. microencapsul |
2008 |
WoS |
21 |
|
3 |
5 |
3 |
|
1 |
2 |
1 |
3 |
3 |
|
Scopus |
28 |
|
5 |
5 |
3 |
|
3 |
2 |
4 |
3 |
3 |
|
165. |
2485361 |
Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD
ligase |
1.01 |
Bioorg. med. chem. lett. |
2009 |
WoS |
20 |
1 |
4 |
1 |
2 |
2 |
|
4 |
2 |
3 |
1 |
|
Scopus |
28 |
1 |
4 |
1 |
3 |
4 |
1 |
4 |
3 |
3 |
3 |
1 |
166. |
4050545 |
Nonpeptidic selective inhibitors of the chymotrypsin-like (ß5i) subunit of the immunoproteasome |
1.01 |
Angew. Chem. |
2016 |
WoS |
27 |
|
|
|
2 |
6 |
6 |
1 |
3 |
6 |
3 |
|
Scopus |
27 |
|
|
|
2 |
6 |
5 |
2 |
3 |
6 |
3 |
|
167. |
1569630 |
Synthetic approaches to contemporary drugs that contain the cyclopropyl moiety |
1.02 |
Synthesis |
2020 |
WoS |
27 |
|
|
|
|
|
|
|
3 |
10 |
13 |
1 |
Scopus |
27 |
|
|
|
|
|
|
|
3 |
11 |
13 |
|
168. |
31824089 |
Cell type-specific response to high intracellular loading of polyacrylic acid-coated
magnetic nanoparticles |
1.01 |
International journal of nanomedicine |
2015 |
WoS |
27 |
|
|
1 |
2 |
5 |
0 |
2 |
3 |
9 |
5 |
|
Scopus |
27 |
|
|
2 |
2 |
5 |
0 |
3 |
2 |
8 |
4 |
1 |
169. |
4736369 |
Synthesis of aminoboronic acid derivatives |
1.02 |
Organic Chemistry Frontiers |
2019 |
WoS |
27 |
|
|
|
|
|
|
3 |
9 |
9 |
6 |
|
Scopus |
26 |
|
|
|
|
|
|
1 |
10 |
9 |
6 |
|
170. |
4240753 |
Design, synthesis and biological evaluation of 4,5-dibromo-N-(thiazol-2-yl)-1H-pyrrole-2-carboxamide
derivatives as novel DNA gyrase inhibitors |
1.01 |
Bioorg. med. chem. |
2017 |
WoS |
26 |
|
|
|
|
2 |
6 |
4 |
7 |
3 |
4 |
|
Scopus |
27 |
|
|
|
|
2 |
7 |
4 |
7 |
4 |
3 |
0 |
171. |
3129713 |
Recent advances in the synthesis of unnatural [alpha]-amino acids - an updated version |
1.02 |
Curr. org. chem. |
2011 |
WoS |
27 |
1 |
5 |
3 |
6 |
3 |
4 |
|
1 |
2 |
2 |
|
Scopus |
26 |
2 |
5 |
3 |
5 |
3 |
3 |
|
1 |
3 |
1 |
|
172. |
26093529 |
49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene
associated with autoimmune thyroid disease |
1.01 |
Hum. immunol. |
2009 |
WoS |
25 |
6 |
2 |
4 |
1 |
5 |
2 |
2 |
2 |
1 |
|
|
Scopus |
27 |
7 |
2 |
5 |
1 |
4 |
2 |
2 |
2 |
1 |
1 |
|
173. |
7794297 |
Fagopyrin and flavonoid contents in common, Tartary, and cymosum buckwheat |
1.03 |
J. food compos. anal. |
2013 |
WoS |
25 |
|
|
1 |
5 |
3 |
1 |
6 |
3 |
5 |
1 |
|
Scopus |
27 |
|
|
2 |
5 |
2 |
2 |
6 |
3 |
5 |
2 |
|
174. |
3363441 |
Environmental risk assessment of antimicrobials applied in veterinary medicine |
1.02 |
Environ Toxicol Pharmacol |
2013 |
WoS |
18 |
|
|
3 |
1 |
0 |
4 |
3 |
1 |
4 |
2 |
|
Scopus |
27 |
1 |
4 |
4 |
2 |
0 |
4 |
3 |
2 |
4 |
3 |
|
175. |
2053233 |
Design, synthesis, biochemical evaluation and antimycobacterial action of phosphonate
inhibitors of antigen 85C, a crucial enzyme involved in biosynthesis of the mycobacterial
cell wall |
1.01 |
Eur. j. med. chem. |
2007 |
WoS |
26 |
4 |
4 |
6 |
|
2 |
3 |
|
3 |
1 |
3 |
|
Scopus |
25 |
4 |
4 |
6 |
|
2 |
3 |
|
3 |
1 |
2 |
|
176. |
2767217 |
Monovalent and bivalent N-fucosyl amides as high affinity ligands for Pseudomonas
aeruginosa PA-IIL lectin |
1.08 |
Carbohydr. res. |
2010 |
WoS |
26 |
8 |
4 |
3 |
3 |
|
1 |
|
1 |
2 |
4 |
|
Scopus |
25 |
8 |
4 |
3 |
3 |
|
1 |
|
1 |
3 |
2 |
|
177. |
3030897 |
Novel 2-thioxothiazolidin-4-one inhibitors of bacterial MurD ligase targeting d-Glu-
and diphosphate-binding site |
1.01 |
Eur. j. med. chem. |
2011 |
WoS |
24 |
|
3 |
3 |
2 |
2 |
3 |
4 |
4 |
1 |
2 |
|
Scopus |
26 |
0 |
3 |
4 |
1 |
3 |
3 |
4 |
5 |
2 |
1 |
|
178. |
2447217 |
Heterozygosity at the TPMT gene locus, augmented by mutated MTHFR gene, predisposes
to 6-MP related toxicities in childhood ALL patients |
1.01 |
Leukemia |
2009 |
WoS |
24 |
|
3 |
7 |
5 |
2 |
2 |
3 |
2 |
|
|
|
Scopus |
26 |
|
3 |
8 |
4 |
3 |
2 |
3 |
3 |
|
|
|
179. |
1724017 |
Synthesis of N-phthalimido [beta]-aminoethanesulfonyl chlorides:the use of chloride
for a simple and efficient synthesis of new peptidosulfonamide building blocks |
1.01 |
Tetrahedron lett. |
2005 |
WoS |
24 |
8 |
3 |
3 |
2 |
2 |
2 |
1 |
1 |
|
2 |
|
Scopus |
26 |
8 |
5 |
4 |
2 |
2 |
2 |
1 |
1 |
|
1 |
|
180. |
2988401 |
Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin-conjugates
for targeting of the gastrin receptor |
1.01 |
J. med. chem. |
2011 |
WoS |
24 |
2 |
1 |
4 |
1 |
1 |
2 |
2 |
8 |
2 |
1 |
|
Scopus |
26 |
2 |
2 |
4 |
1 |
1 |
2 |
2 |
8 |
2 |
2 |
|
181. |
2612441 |
Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired
in motheaten and viable motheaten mice |
1.01 |
J. exp. med. |
1993 |
WoS |
22 |
9 |
|
|
6 |
1 |
1 |
2 |
2 |
1 |
|
|
Scopus |
26 |
11 |
|
1 |
6 |
1 |
1 |
3 |
1 |
2 |
|
|
182. |
2027633 |
Arginine mimetic structures in biologically active antagonists and inhibitors |
1.01 |
Curr. med. chem. |
2006 |
WoS |
16 |
3 |
4 |
2 |
2 |
2 |
1 |
|
|
1 |
1 |
|
Scopus |
26 |
3 |
6 |
4 |
3 |
4 |
3 |
1 |
|
1 |
1 |
|
183. |
24720601 |
Flavonoids, cinnamic acid derivatives as inhibitors of 17 ß-hydroxysteroid dehydrogenase
type 1 |
1.08 |
Mol. cell. endocrinol. |
2009 |
WoS |
24 |
1 |
4 |
3 |
2 |
2 |
|
2 |
4 |
1 |
3 |
2 |
Scopus |
25 |
1 |
4 |
3 |
2 |
2 |
1 |
3 |
3 |
2 |
2 |
2 |
184. |
1813873 |
Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto
reductase AKR1C3: new lead compounds for the development of anticancer agents |
1.01 |
Bioorg. med. chem. lett. |
2005 |
WoS |
25 |
2 |
6 |
|
2 |
5 |
1 |
2 |
4 |
1 |
2 |
|
Scopus |
24 |
2 |
6 |
|
2 |
4 |
1 |
2 |
4 |
1 |
2 |
|
185. |
6147866 |
Stereopure functionalized benzosultams via ruthenium(II)-catalyzed dynamic kinetic
resolution-asymmetric transfer hydrogenation |
1.01 |
Org. lett. |
2017 |
WoS |
22 |
|
|
|
|
|
8 |
2 |
6 |
5 |
1 |
|
Scopus |
25 |
|
|
|
|
|
8 |
2 |
5 |
8 |
2 |
|
186. |
33728005 |
Comparison of isolation methods for the determination of buckwheat volatile compounds |
1.01 |
Food chem. |
2010 |
WoS |
22 |
6 |
3 |
|
2 |
3 |
2 |
1 |
1 |
2 |
1 |
1 |
Scopus |
25 |
6 |
4 |
1 |
2 |
3 |
2 |
2 |
1 |
2 |
1 |
1 |
187. |
1900657 |
Cinnamic acids as new inhibitors of 17ß-hydroxysteroid dehydrogenase type 5 (AKR1C3) |
1.08 |
Mol. cell. endocrinol. |
2006 |
WoS |
22 |
3 |
4 |
2 |
1 |
4 |
1 |
2 |
2 |
1 |
2 |
|
Scopus |
25 |
3 |
5 |
2 |
1 |
4 |
3 |
2 |
2 |
1 |
2 |
|
188. |
10675540 |
Cell electrofusion |
1.02 |
Expert opinion on drug delivery |
2014 |
WoS |
21 |
|
|
1 |
6 |
3 |
2 |
1 |
2 |
|
5 |
1 |
Scopus |
25 |
|
|
2 |
6 |
4 |
3 |
0 |
3 |
2 |
4 |
1 |
189. |
5493018 |
Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors
of bacterial Mur ligases (MurC-MurF) |
1.01 |
Bioorg. med. chem. |
2014 |
WoS |
23 |
|
1 |
0 |
1 |
7 |
|
8 |
5 |
0 |
1 |
|
Scopus |
24 |
|
1 |
0 |
1 |
8 |
1 |
6 |
6 |
0 |
1 |
|
190. |
9897812 |
Effect of different parameters used for in vitro gene electrotransfer on gene expression
efficiency, cell viability and visualization of plasmid DNA at the membrane level |
1.01 |
J. gene med. |
2013 |
WoS |
22 |
|
1 |
3 |
2 |
1 |
2 |
1 |
5 |
4 |
3 |
|
Scopus |
24 |
0 |
1 |
3 |
4 |
2 |
2 |
1 |
5 |
3 |
3 |
|
191. |
3563377 |
Specificity determinants for lysine incorporation in Staphylococcus aureus peptidoglycan
as revealed by the structure of a MurE enzyme ternary complex |
1.01 |
J Biol Chem |
2013 |
WoS |
22 |
|
3 |
1 |
1 |
1 |
3 |
5 |
5 |
1 |
2 |
|
Scopus |
24 |
|
3 |
1 |
2 |
1 |
3 |
5 |
5 |
1 |
3 |
|
192. |
4843377 |
Vegetable butters and oils in skin wound healing |
1.02 |
Phytother. res. |
2020 |
WoS |
22 |
|
|
|
|
|
|
|
2 |
10 |
9 |
1 |
Scopus |
24 |
|
|
|
|
|
|
|
3 |
10 |
9 |
2 |
193. |
2505585 |
Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD
and MurF by structure-based virtual screening |
1.01 |
Bioorg. med. chem. |
2009 |
WoS |
21 |
2 |
1 |
1 |
0 |
2 |
2 |
6 |
3 |
2 |
2 |
|
Scopus |
24 |
2 |
1 |
1 |
0 |
4 |
2 |
5 |
5 |
1 |
3 |
|
194. |
4757617 |
Chalcone derivatives |
1.01 |
Heliyon |
2019 |
WoS |
20 |
|
|
|
|
|
|
|
4 |
8 |
7 |
1 |
Scopus |
24 |
|
|
|
|
|
|
1 |
4 |
9 |
8 |
2 |
195. |
7830612 |
Cell-cell electrofusion |
1.01 |
J. membr. biol. |
2010 |
WoS |
18 |
3 |
2 |
2 |
1 |
1 |
3 |
1 |
1 |
0 |
4 |
|
Scopus |
24 |
3 |
2 |
3 |
3 |
1 |
3 |
2 |
1 |
3 |
3 |
|
196. |
2232177 |
Inhibitors of 17[beta]-hydroxysteroid dehydrogenase type 1 |
1.02 |
Curr. med. chem. |
2008 |
WoS |
23 |
2 |
2 |
1 |
5 |
4 |
1 |
5 |
1 |
1 |
1 |
|
Scopus |
23 |
3 |
1 |
1 |
5 |
4 |
1 |
5 |
1 |
1 |
1 |
|
197. |
3886961 |
4,6- substituted-1,3,5-triazin-2(1H)-ones as monocyclic catalytic inhibitors of human
DNA topoisomerase II [alpha] targeting the ATP binding site |
1.01 |
Bioorg. med. chem. |
2015 |
WoS |
22 |
|
|
|
2 |
6 |
6 |
2 |
3 |
0 |
3 |
|
Scopus |
23 |
|
|
0 |
2 |
6 |
6 |
2 |
3 |
2 |
2 |
|
198. |
4515441 |
Recent progress in the discovery and development of DNA gyrase B inhibitors |
1.02 |
Future medicinal chemistry |
2018 |
WoS |
22 |
|
|
|
|
|
2 |
4 |
5 |
4 |
7 |
|
Scopus |
23 |
|
|
|
|
|
2 |
3 |
6 |
5 |
7 |
|
199. |
4686961 |
An optimised series of substituted N-phenylpyrrolamides as DNA gyrase B inhibitors |
1.01 |
Eur. j. med. chem. |
2019 |
WoS |
22 |
|
|
|
|
|
|
4 |
7 |
3 |
7 |
1 |
Scopus |
23 |
|
|
|
|
|
|
4 |
7 |
3 |
8 |
1 |
200. |
3557745 |
Isolation, analysis and structures of phototoxic fagopyrins from buckwheat |
1.01 |
Food chem. |
2014 |
WoS |
22 |
|
|
1 |
3 |
2 |
1 |
2 |
3 |
7 |
3 |
|
Scopus |
23 |
|
|
1 |
3 |
1 |
2 |
4 |
3 |
6 |
3 |
|
201. |
2637169 |
Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis
enzymes MurC to MurF |
1.01 |
Bioorg. chem. |
2009 |
WoS |
21 |
1 |
1 |
|
2 |
|
1 |
5 |
8 |
2 |
1 |
|
Scopus |
23 |
1 |
1 |
1 |
2 |
|
1 |
5 |
9 |
2 |
1 |
|
202. |
34441989 |
Lactone pathway to statins utilizing the Wittig reaction. The synthesis of rosuvastatin |
1.01 |
J. org. chem. |
2010 |
WoS |
19 |
1 |
4 |
7 |
0 |
2 |
1 |
2 |
1 |
1 |
|
|
Scopus |
23 |
1 |
5 |
7 |
2 |
2 |
1 |
1 |
1 |
2 |
1 |
|
203. |
3499889 |
Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells |
1.01 |
Neuropharmacology |
2014 |
WoS |
22 |
|
|
1 |
3 |
4 |
4 |
3 |
3 |
1 |
3 |
|
Scopus |
22 |
|
0 |
1 |
3 |
4 |
4 |
3 |
3 |
1 |
3 |
|
204. |
4461681 |
Synthesis and evaluation of N-phenylpyrrolamides as DNA gyrase B inhibitors |
1.01 |
ChemMedChem |
2018 |
WoS |
22 |
|
|
|
|
|
0 |
3 |
7 |
8 |
3 |
1 |
Scopus |
22 |
|
|
|
|
|
0 |
3 |
7 |
7 |
4 |
1 |
205. |
4723057 |
A MedChem toolbox for cereblon-directed PROTACs |
1.01 |
MedChemComm |
2019 |
WoS |
22 |
|
|
|
|
|
|
1 |
3 |
6 |
10 |
2 |
Scopus |
22 |
|
|
|
|
|
|
1 |
4 |
6 |
9 |
2 |
206. |
4684145 |
ATP-competitive DNA gyrase and topoisomerase IV inhibitors as antibacterial agents |
1.02 |
Expert opin. ther. pat. |
2019 |
WoS |
22 |
|
|
|
|
|
|
0 |
7 |
9 |
6 |
|
Scopus |
22 |
|
|
|
|
|
|
0 |
7 |
8 |
7 |
0 |
207. |
3008113 |
Development of screening assays and discovery of initial inhibitors of pneumococcal
peptidoglycan deacetylase PgdA |
1.01 |
Biochem. pharmacol. |
2011 |
WoS |
21 |
1 |
3 |
2 |
|
3 |
5 |
2 |
2 |
2 |
1 |
|
Scopus |
22 |
1 |
3 |
1 |
|
3 |
5 |
3 |
3 |
2 |
1 |
|
208. |
30127109 |
Design and synthesis of new hydroxyethylamines as inhibitors of D-alanyl-D-lactate
ligase (VanA) and D-alanyl-D-alanine ligase (DdlB) |
1.01 |
Bioorg. med. chem. lett. |
2009 |
WoS |
21 |
2 |
2 |
1 |
3 |
1 |
3 |
2 |
3 |
1 |
3 |
|
Scopus |
22 |
2 |
3 |
1 |
4 |
|
2 |
2 |
3 |
2 |
3 |
|
209. |
4164977 |
Clioquinol-ruthenium complex impairs tumour cell invasion by inhibiting cathepsin
B activity |
1.01 |
Dalton trans. |
2016 |
WoS |
21 |
|
|
|
|
0 |
4 |
6 |
5 |
5 |
1 |
|
Scopus |
22 |
|
|
|
|
2 |
3 |
6 |
5 |
5 |
1 |
|
210. |
1586012 |
Cobalt-catalyzed cross-coupling of Grignards with allylic and vinylic bromides |
1.01 |
J. org. chem. |
2015 |
WoS |
21 |
|
|
3 |
3 |
2 |
4 |
2 |
3 |
3 |
1 |
|
Scopus |
22 |
|
|
3 |
3 |
2 |
5 |
2 |
3 |
3 |
1 |
|
211. |
3638897 |
Excretion pattern of enrofloxacin after oral treatment of chicken broilers |
1.03 |
J. vet. pharmacol. ther. |
2014 |
WoS |
20 |
|
1 |
|
6 |
2 |
2 |
2 |
|
7 |
|
|
Scopus |
22 |
|
1 |
|
6 |
2 |
2 |
3 |
|
7 |
|
1 |
212. |
4022897 |
Synthesis and biological assessment of racemic benzochromenopyrimidinimines as antioxidant,
cholinesterase, and A[sub]ß1-42 aggregation Inhibitors for Alzheimer's disease therapy |
1.01 |
ChemMedChem |
2016 |
WoS |
20 |
|
|
|
1 |
8 |
1 |
3 |
4 |
2 |
1 |
|
Scopus |
22 |
|
|
|
1 |
10 |
1 |
3 |
3 |
3 |
1 |
|
213. |
512412216 |
Relationship between genome and epigenome - challenges and requirements for future
research |
1.03 |
BMC Genomics |
2014 |
WoS |
19 |
|
1 |
6 |
4 |
2 |
1 |
3 |
|
|
2 |
|
Scopus |
22 |
|
1 |
6 |
4 |
4 |
1 |
3 |
|
1 |
2 |
|
214. |
4176497 |
Mutagenic and carcinogenic structural alerts and their mechanisms of action |
1.02 |
Arh. hig. rada toksikol. |
2016 |
WoS |
19 |
|
|
|
|
|
2 |
5 |
7 |
4 |
1 |
|
Scopus |
22 |
|
|
|
|
|
2 |
6 |
9 |
4 |
1 |
|
215. |
6029908 |
Electroporator with automatic change of electric field direction improves gene electrotransfer
in-vitro |
1.01 |
Biomed. eng. online |
2007 |
WoS |
18 |
1 |
4 |
|
2 |
3 |
1 |
3 |
2 |
2 |
|
|
Scopus |
22 |
1 |
4 |
|
1 |
4 |
3 |
3 |
2 |
2 |
1 |
1 |
216. |
4133233 |
PACSIN2 polymorphism is associated with thiopurineinduced hematological toxicity in
children with acute lymphoblastic leukaemia undergoing maintenance therapy |
1.01 |
Sci. rep. |
2016 |
WoS |
16 |
|
|
|
|
2 |
1 |
4 |
5 |
2 |
2 |
|
Scopus |
22 |
|
|
|
|
3 |
1 |
7 |
5 |
3 |
3 |
|
217. |
1421660 |
Optimized method for determination of amoxicillin, ampicillin, sulfamethoxazole, and
sulfacetamide in animal feed by micellar electrokinetic capillary chromatography and
comparison with high-performance liquid chromatography |
1.01 |
Croat. chem. acta |
2009 |
WoS |
14 |
1 |
1 |
|
2 |
2 |
1 |
3 |
1 |
1 |
2 |
|
Scopus |
22 |
3 |
1 |
|
2 |
3 |
1 |
3 |
3 |
1 |
3 |
2 |
218. |
4880241 |
Two-decades of successful SAR-grounded stories of the novel bacterial topoisomerase
inhibitors (NBTIs) |
1.01 |
J. med. chem. |
2020 |
WoS |
21 |
|
|
|
|
|
|
|
1 |
7 |
13 |
|
Scopus |
21 |
|
|
|
|
|
|
|
1 |
8 |
12 |
|
219. |
3001457 |
Second-generation sulfonamide inhibitors of d-glutamic acid-adding enzyme: activity
optimisation with conformationally rigid analogues of d-glutamic acid |
1.01 |
Eur. j. med. chem. |
2011 |
WoS |
21 |
3 |
2 |
1 |
2 |
2 |
2 |
5 |
3 |
1 |
|
|
Scopus |
21 |
3 |
2 |
1 |
1 |
2 |
1 |
4 |
4 |
2 |
1 |
|
220. |
4083825 |
Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase
inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's disease |
1.01 |
Molecules |
2016 |
WoS |
21 |
|
|
|
1 |
4 |
|
5 |
3 |
4 |
3 |
1 |
Scopus |
21 |
|
|
|
1 |
4 |
|
5 |
3 |
4 |
4 |
|
221. |
7818836 |
The role of electrophoresis in gene electrotransfer |
1.01 |
J. membr. biol. |
2010 |
WoS |
20 |
2 |
5 |
2 |
1 |
1 |
1 |
|
|
4 |
4 |
|
Scopus |
21 |
3 |
4 |
3 |
1 |
2 |
1 |
|
|
5 |
2 |
|
222. |
512549944 |
Advanced therapies of skin injuries |
1.02 |
Wien. Klin. Wochenschr. |
2015 |
WoS |
19 |
|
|
|
|
1 |
5 |
5 |
3 |
3 |
1 |
1 |
Scopus |
21 |
|
|
|
|
3 |
3 |
5 |
3 |
3 |
3 |
1 |
223. |
3630449 |
Inhibition of biofilm formation by conformationally constrained indole-based analogues
of the marine alkaloid oroidin |
1.01 |
Bioorg. med. chem. lett. |
2014 |
WoS |
18 |
|
|
2 |
2 |
2 |
4 |
3 |
4 |
1 |
|
|
Scopus |
21 |
|
|
2 |
2 |
3 |
5 |
3 |
4 |
2 |
|
|
224. |
21450969 |
Flavonoids and cinnamic acid esters as inhibitors of fungal 17ß-hydroxysteroid dehydrogenase |
1.01 |
Bioorg. med. chem. |
2006 |
WoS |
18 |
2 |
3 |
1 |
2 |
1 |
2 |
2 |
|
2 |
3 |
|
Scopus |
21 |
2 |
4 |
1 |
2 |
1 |
3 |
3 |
|
2 |
3 |
|
225. |
1961841 |
Surface analysis of powder binary mixtures with ATR FTIR spectroscopy |
1.01 |
Int. j. pharm. |
2006 |
WoS |
16 |
3 |
1 |
3 |
2 |
2 |
1 |
1 |
2 |
|
1 |
|
Scopus |
21 |
3 |
3 |
3 |
2 |
2 |
2 |
2 |
2 |
|
1 |
1 |
226. |
4154993 |
S-adenosyl methionine in the therapy of depression and other psychiatric disorders. |
1.02 |
Drug dev. res. |
2016 |
WoS |
16 |
|
|
|
|
|
|
2 |
7 |
5 |
1 |
1 |
Scopus |
21 |
|
|
|
1 |
1 |
2 |
2 |
9 |
4 |
1 |
1 |
227. |
3979633 |
Inhibition of endopeptidase and exopeptidase activity of cathepsin B impairs extracellular
matrix degradation and tumour invasion |
1.01 |
Biol Chem |
2016 |
WoS |
21 |
|
|
|
1 |
3 |
1 |
4 |
3 |
3 |
6 |
|
Scopus |
16 |
|
|
|
1 |
3 |
1 |
3 |
1 |
2 |
5 |
|
228. |
4634737 |
The pore-forming action of polyenes |
1.02 |
Biochim. biophys. acta, Biomembr. |
2019 |
WoS |
15 |
|
|
|
|
|
|
|
3 |
7 |
5 |
|
Scopus |
21 |
|
|
|
|
|
|
|
3 |
9 |
8 |
1 |
229. |
4872561 |
Stereoselective activity of 1-propargyl-4-styrylpiperidine-like analogues that can
discriminate between monoamine oxidase isoforms A and B |
1.01 |
J. med. chem. |
2020 |
WoS |
20 |
|
|
|
|
|
|
|
4 |
6 |
10 |
|
Scopus |
20 |
|
|
|
|
|
|
|
4 |
7 |
9 |
|
230. |
2162801 |
New biologically active epidioxysterols from Stereum hirsutum |
1.01 |
Bioorg. med. chem. lett. |
2007 |
WoS |
20 |
1 |
4 |
|
2 |
1 |
2 |
|
6 |
2 |
2 |
|
Scopus |
20 |
1 |
4 |
|
2 |
1 |
2 |
1 |
6 |
1 |
2 |
|
231. |
2063985 |
Diazenedicarboxamides as inhibitors of D-alanine-D-alanine ligase (Ddl) |
1.01 |
Bioorg. med. chem. lett. |
2007 |
WoS |
19 |
0 |
3 |
2 |
1 |
|
3 |
2 |
3 |
4 |
1 |
|
Scopus |
20 |
0 |
3 |
2 |
1 |
|
4 |
2 |
3 |
4 |
1 |
|
232. |
4505201 |
Overcoming problems of poor drug penetration into bacteria |
1.02 |
Expert opinion on drug discovery |
2018 |
WoS |
19 |
|
|
|
|
|
1 |
8 |
3 |
3 |
3 |
1 |
Scopus |
20 |
|
|
|
|
|
2 |
8 |
3 |
4 |
2 |
1 |
233. |
4427121 |
Benzothiazole-based compounds in antibacterial drug discovery |
1.02 |
Curr. med. chem. |
2018 |
WoS |
19 |
|
|
|
|
|
1 |
|
5 |
5 |
8 |
|
Scopus |
20 |
|
|
|
|
|
1 |
1 |
4 |
5 |
8 |
1 |
234. |
4118897 |
Comparison of in vitro hormone activities of novel flame retardants TBB, TBPH and
their metabolites TBBA and TBMEPH using reporter gene assays |
1.01 |
Chemosphere |
2016 |
WoS |
19 |
|
|
|
|
2 |
3 |
4 |
3 |
5 |
2 |
|
Scopus |
20 |
|
|
|
0 |
2 |
3 |
4 |
3 |
5 |
3 |
|
235. |
3580017 |
Design, synthesis and evaluation of second generation MurF inhibitors based ona cyanothiophene
scaffold |
1.01 |
Eur. j. med. chem. |
2014 |
WoS |
19 |
|
1 |
|
|
5 |
1 |
3 |
3 |
2 |
4 |
|
Scopus |
20 |
|
1 |
|
|
6 |
1 |
2 |
5 |
1 |
4 |
|
236. |
4728346 |
Ellipticines and 9-acridinylamines as inhibitors of d-alanine |
1.01 |
Bioorg. med. chem. |
2011 |
WoS |
18 |
1 |
3 |
2 |
2 |
|
3 |
2 |
2 |
2 |
1 |
|
Scopus |
20 |
1 |
3 |
2 |
2 |
1 |
3 |
2 |
2 |
3 |
1 |
|
237. |
4051313 |
Synthesis, molecular modelling and biological evaluation of novel heterodimeric, multiple
ligands targeting cholinesterases and amyloid beta |
1.01 |
Molecules |
2016 |
WoS |
18 |
|
|
|
3 |
2 |
6 |
4 |
3 |
0 |
|
|
Scopus |
20 |
|
|
|
3 |
2 |
6 |
5 |
4 |
0 |
0 |
|
238. |
5677082 |
Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors
of the bacterial Mur ligases (MurC-MurF) |
1.01 |
J. comput.-aided mol. des. |
2015 |
WoS |
18 |
|
|
|
0 |
9 |
2 |
3 |
3 |
0 |
1 |
|
Scopus |
20 |
|
|
|
0 |
10 |
3 |
1 |
4 |
1 |
1 |
|
239. |
2895473 |
Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists |
1.01 |
Molecular diversity |
2011 |
WoS |
19 |
3 |
1 |
1 |
4 |
2 |
3 |
1 |
2 |
1 |
1 |
|
Scopus |
19 |
3 |
1 |
2 |
4 |
1 |
3 |
|
3 |
1 |
1 |
|
240. |
3007857 |
New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant
bacteria |
1.01 |
PloS one |
2011 |
WoS |
19 |
5 |
5 |
|
1 |
2 |
1 |
0 |
1 |
4 |
|
|
Scopus |
19 |
5 |
4 |
|
2 |
2 |
1 |
0 |
2 |
3 |
|
|
241. |
9419860 |
The systematic study of the electroporation and electrofusion of B16-F1 and CHO cells
in isotonic and hypotonic buffer |
1.08 |
J. membr. biol. |
2012 |
WoS |
19 |
3 |
3 |
1 |
1 |
2 |
3 |
1 |
2 |
|
3 |
|
Scopus |
19 |
3 |
3 |
2 |
1 |
1 |
3 |
2 |
|
1 |
3 |
|
242. |
6273306 |
Identification of conserved water sites in protein structures for drug design |
1.01 |
J. chem. inf. mod. |
2017 |
WoS |
19 |
|
|
|
|
|
2 |
3 |
5 |
4 |
5 |
|
Scopus |
19 |
|
|
|
|
|
2 |
3 |
5 |
4 |
5 |
|
243. |
4058394 |
Discovery of new inhibitors of D-alanine:D-alanine ligase by structure-based virtual
screening |
1.01 |
J. med. chem. |
2008 |
WoS |
19 |
1 |
3 |
2 |
1 |
2 |
3 |
1 |
2 |
1 |
3 |
|
Scopus |
18 |
1 |
3 |
1 |
1 |
2 |
3 |
1 |
2 |
1 |
3 |
|
244. |
32332327 |
trans-Diastereoselective Ru(II)-catalyzed asymmetric transfer hydrogenation of [alpha]-acetamido
benzocyclic ketones via dynamic kinetic resolution |
1.01 |
Org. lett. |
2019 |
WoS |
18 |
|
|
|
|
|
|
3 |
4 |
7 |
4 |
|
Scopus |
19 |
|
|
|
|
|
|
2 |
4 |
8 |
5 |
|
245. |
1670001 |
Design and synthesis of novel platelet fibrinogen receptor antagonists with 2H-1,4-benzoxazine-3(4H)-one
scaffold. A systematic study |
1.01 |
Eur. j. med. chem. |
2005 |
WoS |
18 |
1 |
4 |
2 |
1 |
3 |
4 |
1 |
1 |
1 |
|
|
Scopus |
19 |
1 |
5 |
|
2 |
4 |
4 |
1 |
|
2 |
|
|
246. |
3556209 |
2-aminoimidazoles in medicinal chemistry |
1.02 |
Mini rev. med. chem. |
2013 |
WoS |
18 |
|
2 |
2 |
3 |
3 |
1 |
4 |
1 |
2 |
|
|
Scopus |
19 |
|
2 |
2 |
3 |
4 |
1 |
4 |
1 |
2 |
|
|
247. |
2843249 |
3D QSAR study, synthesis and in vitro evaluation of (+)-5-FBVM as potential PET radioligand
for the Vesicular AcetylCholine Transporter (VAChT) |
1.01 |
Bioorg. med. chem. |
2010 |
WoS |
18 |
2 |
2 |
1 |
2 |
2 |
2 |
1 |
3 |
1 |
2 |
|
Scopus |
19 |
2 |
2 |
1 |
2 |
2 |
2 |
1 |
4 |
1 |
2 |
|
248. |
3299953 |
Excretion profile of glycyrrhizin metabolite in human urine |
1.01 |
Food chem. |
2012 |
WoS |
18 |
|
|
4 |
1 |
|
3 |
1 |
4 |
2 |
3 |
|
Scopus |
19 |
1 |
1 |
3 |
1 |
1 |
3 |
1 |
4 |
2 |
2 |
|
249. |
3363185 |
Computational study of reactivity of bisphenol A-3,4-quinone with deoxyadenosine and
glutathione |
1.01 |
Chem. res. toxicol. |
2013 |
WoS |
18 |
2 |
4 |
3 |
2 |
1 |
2 |
1 |
|
1 |
2 |
|
Scopus |
19 |
2 |
5 |
2 |
2 |
1 |
2 |
1 |
1 |
1 |
2 |
|
250. |
3319921 |
Three-dimensional invasion of macrophages is mediated by cysteine cathepsins in protrusive
podosomes |
1.01 |
Eur J Immunol |
2012 |
WoS |
19 |
2 |
4 |
4 |
0 |
2 |
1 |
2 |
2 |
1 |
1 |
|
Scopus |
18 |
2 |
4 |
4 |
0 |
2 |
1 |
2 |
1 |
1 |
1 |
|
251. |
4620401 |
Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite |
1.01 |
Chemosphere |
2019 |
WoS |
18 |
|
|
|
|
|
|
2 |
2 |
7 |
7 |
|
Scopus |
19 |
|
|
|
|
|
|
2 |
2 |
7 |
7 |
1 |
252. |
3978865 |
Structure-activity relationships of novel tryptamine-based inhibitors of bacterial
transglycosylase |
1.01 |
J. med. chem. |
2015 |
WoS |
17 |
|
|
|
2 |
4 |
1 |
|
5 |
3 |
2 |
|
Scopus |
19 |
|
|
|
3 |
4 |
1 |
|
5 |
4 |
2 |
|
253. |
38739715 |
Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets |
1.02 |
Pharmacol. ther. |
2021 |
WoS |
17 |
|
|
|
|
|
|
|
|
6 |
11 |
|
Scopus |
19 |
|
|
|
|
|
|
|
|
7 |
11 |
1 |
254. |
2286193 |
Novel potent and selective thrombin inhibitors based on a central 1,4-benzoxazin-3(4H)-one
scaffold |
1.01 |
J. med. chem. |
2008 |
WoS |
19 |
|
3 |
4 |
2 |
3 |
3 |
1 |
|
2 |
1 |
|
Scopus |
17 |
|
4 |
5 |
2 |
2 |
0 |
1 |
|
2 |
1 |
|
255. |
1993073 |
A new approach towards peptidosulfonamides: synthesis of potential inhibitors of bacterial
peptidoglycan biosynthesis enzymes MurD and MurE |
1.01 |
Tetrahedron |
2006 |
WoS |
16 |
1 |
1 |
1 |
|
3 |
2 |
2 |
3 |
3 |
|
|
Scopus |
19 |
1 |
1 |
1 |
|
4 |
2 |
2 |
4 |
3 |
1 |
|
256. |
3520881 |
MurD enzymes: some recent developments |
1.02 |
Biomol. concepts |
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Scopus |
19 |
|
0 |
0 |
2 |
3 |
0 |
4 |
2 |
4 |
4 |
|
257. |
1513585 |
Phosphonate inhibitors of antigen 85C, a crucial enzyme involved in the biosynthesis
of the Mycobacterium tuberculosis cell wall |
1.01 |
Bioorg. med. chem. lett. |
2004 |
WoS |
19 |
|
2 |
2 |
1 |
4 |
2 |
2 |
2 |
2 |
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
258. |
1552497 |
Phosphonate inhibitors of antigen 85C, a crucial enzyme involved in the biosynthesis
of the Mycobacterium tuberculosis cell wall |
1.12 |
16th International Conference on Phosphorus Chemistry |
2004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Scopus |
19 |
|
2 |
2 |
1 |
4 |
2 |
2 |
2 |
2 |
2 |
|
259. |
5867290 |
Non-targeted chromatographic analyses of cuticular wax flavonoids from Physalis alkekengi
L. |
1.01 |
J. chromatogr., A |
2016 |
WoS |
18 |
|
|
|
0 |
4 |
3 |
3 |
2 |
4 |
2 |
|
Scopus |
18 |
|
|
|
0 |
4 |
3 |
3 |
3 |
3 |
2 |
|
260. |
4857713 |
1-benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant
and metal-chelating properties as multifunctional agents against Alzheimer's disease |
1.01 |
Eur. j. med. chem. |
2020 |
WoS |
18 |
|
|
|
|
|
|
|
4 |
5 |
8 |
1 |
Scopus |
18 |
|
|
|
|
|
|
|
4 |
5 |
8 |
1 |
261. |
3440241 |
Low molecular weight dual inhibitors of factor Xa and fibrinogen binding to GPIIb/IIIa
with highly overlapped pharmacophores |
1.01 |
Eur. j. med. chem. |
2013 |
WoS |
18 |
0 |
0 |
5 |
2 |
3 |
3 |
3 |
1 |
1 |
|
|
Scopus |
18 |
0 |
0 |
5 |
2 |
3 |
3 |
3 |
1 |
1 |
|
|
262. |
4623217 |
Reaching toward underexplored targets in antibacterial drug design |
1.03 |
Drug dev. res. |
2019 |
WoS |
18 |
|
|
|
|
|
|
3 |
4 |
7 |
4 |
|
Scopus |
18 |
|
|
|
|
|
|
3 |
4 |
6 |
4 |
1 |
263. |
4473713 |
Design, synthesis, and biological evaluation of 2-(benzylamino-2-hydroxyalkyl)isoindoline-1,3-diones
derivatives as potential disease-modifying multifunctional anti-Alzheimer agents |
1.01 |
Molecules |
2018 |
WoS |
18 |
|
|
|
|
|
3 |
3 |
6 |
3 |
3 |
|
Scopus |
18 |
|
|
|
|
|
3 |
3 |
6 |
3 |
3 |
|
264. |
30102311 |
Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis
and worsened by the neutralization of tumor necrosis Factor [alpha] |
1.01 |
International immunopharmacology |
2017 |
WoS |
18 |
|
|
|
|
1 |
2 |
4 |
3 |
3 |
5 |
|
Scopus |
18 |
|
|
|
|
1 |
2 |
4 |
3 |
4 |
4 |
|
265. |
1487196 |
Concise and highly efficient approach to three key pyrimidine precursors for rosuvastatin
synthesis |
1.01 |
Tetrahedron |
2012 |
WoS |
18 |
1 |
5 |
4 |
2 |
3 |
1 |
1 |
|
|
1 |
|
Scopus |
18 |
1 |
5 |
5 |
2 |
3 |
1 |
1 |
|
|
|
|
266. |
3602033 |
Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of
the receptor |
1.01 |
Eur. j. med. chem. |
2014 |
WoS |
17 |
|
0 |
0 |
0 |
3 |
2 |
3 |
1 |
4 |
4 |
|
Scopus |
18 |
|
0 |
1 |
0 |
2 |
2 |
3 |
2 |
4 |
4 |
|
267. |
4504945 |
New N-phenylpyrrolamide DNA gyrase B inhibitors |
1.01 |
Eur. j. med. chem. |
2018 |
WoS |
17 |
|
|
|
|
|
|
3 |
6 |
5 |
3 |
|
Scopus |
18 |
|
|
|
|
|
|
2 |
8 |
4 |
3 |
1 |
268. |
3492977 |
Cinnamic Acid derivatives induce cell cycle arrest in carcinoma cell lines |
1.01 |
Medicinal chemistry |
2013 |
WoS |
17 |
|
1 |
1 |
1 |
|
2 |
|
3 |
6 |
2 |
1 |
Scopus |
18 |
|
1 |
1 |
1 |
1 |
2 |
|
3 |
5 |
2 |
2 |
269. |
27778009 |
Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3 |
1.08 |
Chem.-biol. interact. |
2011 |
WoS |
17 |
0 |
5 |
0 |
3 |
3 |
1 |
1 |
0 |
2 |
2 |
|
Scopus |
18 |
0 |
4 |
2 |
3 |
3 |
1 |
1 |
|
2 |
2 |
|
270. |
3789425 |
Glucocorticoid-like activity of propylparaben, butylparaben, diethylhexyl phthalate
and tetramethrin mixtures studied in the MDA-kb2 cell line |
1.01 |
Toxicol. lett. |
2015 |
WoS |
18 |
|
|
0 |
|
4 |
2 |
3 |
3 |
5 |
1 |
|
Scopus |
17 |
|
|
0 |
|
4 |
1 |
3 |
3 |
5 |
1 |
|
271. |
2281585 |
A convenient synthesis of 3,4-dihydro-1,4-benzoxazin-2-ones |
1.01 |
Tetrahedron |
2008 |
WoS |
17 |
|
2 |
|
1 |
4 |
4 |
1 |
3 |
2 |
|
|
Scopus |
18 |
|
2 |
|
1 |
4 |
4 |
1 |
3 |
3 |
|
|
272. |
4025969 |
New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran
scaffold |
1.01 |
Eur. j. med. chem. |
2016 |
WoS |
16 |
|
|
|
1 |
3 |
4 |
1 |
4 |
1 |
2 |
|
Scopus |
18 |
|
|
|
1 |
3 |
4 |
1 |
4 |
2 |
3 |
|
273. |
3888753 |
N-phenyl-4,5-dibromopyrrolamides and N-phenylindolamides as ATP competitive DNA gyrase
B inhibitors |
1.01 |
J. med. chem. |
2015 |
WoS |
16 |
|
|
|
2 |
2 |
2 |
3 |
4 |
2 |
1 |
|
Scopus |
18 |
|
|
1 |
1 |
2 |
2 |
3 |
4 |
2 |
3 |
0 |
274. |
977521 |
Trimethylsilyldiazomethane in the preparation of diazoketones via mixed anhydride
and coupling reagent methods: a new approach to the Arndt-Eistert synthesis |
1.01 |
Tetrahedron lett. |
2001 |
WoS |
16 |
2 |
1 |
1 |
3 |
1 |
1 |
3 |
2 |
1 |
1 |
|
Scopus |
18 |
2 |
2 |
1 |
3 |
1 |
2 |
3 |
2 |
1 |
1 |
|
275. |
3075953 |
A 1:1 cocrystal of fluconazole with salicylic acid |
1.01 |
Acta crystallogr., C Cryst. struct. commun. |
2011 |
WoS |
15 |
|
3 |
1 |
1 |
1 |
2 |
2 |
3 |
|
2 |
|
Scopus |
18 |
0 |
4 |
2 |
1 |
1 |
2 |
4 |
2 |
1 |
1 |
|
276. |
7142996 |
Cell size dynamics and viability of cells exposed to hypotonic treatment and electroporation
for electrofusion optimization |
1.01 |
Radiol. oncol. |
2009 |
WoS |
15 |
1 |
1 |
2 |
1 |
2 |
1 |
1 |
2 |
1 |
3 |
|
Scopus |
18 |
1 |
2 |
3 |
1 |
2 |
1 |
1 |
3 |
1 |
3 |
|
277. |
4795256 |
Identification, in vitro and in vivo antioxidant activity, and gastrointestinal stability
of lignans from silver fir (abies alba) wood extract |
1.01 |
J. wood chem. technol. |
2017 |
WoS |
14 |
|
|
|
|
|
1 |
3 |
2 |
4 |
3 |
1 |
Scopus |
18 |
|
|
|
|
|
1 |
3 |
3 |
5 |
5 |
1 |
278. |
31851523 |
Pyrimido[1,2-b]indazole derivatives |
1.01 |
Eur. j. med. chem. |
2021 |
WoS |
17 |
|
|
|
|
|
|
|
|
6 |
10 |
1 |
Scopus |
17 |
|
|
|
|
|
|
|
|
6 |
10 |
1 |
279. |
1718641 |
Toward a novel class of antithrombotic compounds with dual function. Discovery of
1,4-benzoxazin-3(4H)-one derivatives possessing thrombin inhibitory and fibrinogen
receptor antagonistic activities. |
1.01 |
J. med. chem. |
2005 |
WoS |
17 |
1 |
5 |
3 |
2 |
3 |
2 |
|
|
|
1 |
|
Scopus |
17 |
1 |
5 |
2 |
3 |
3 |
2 |
|
|
|
1 |
|
280. |
2074737 |
Biochemical characterization and physiological properties of Escherichia coli UDP-N-acetylmuramate:L-alanyl-[gamma]-D-glutamyl-meso-diaminopimelate
ligase (Mpl) |
1.01 |
J Bacteriol |
2007 |
WoS |
17 |
2 |
2 |
1 |
1 |
2 |
3 |
1 |
1 |
4 |
|
|
Scopus |
17 |
2 |
2 |
1 |
1 |
2 |
3 |
1 |
1 |
4 |
|
|
281. |
3286897 |
6-arylpyrido[2,3-d]pyrimidines as novel ATP-competitive inhibitors of bacterial D-alanine:
D-alanine ligase |
1.01 |
PloS one |
2012 |
WoS |
16 |
0 |
4 |
3 |
2 |
|
2 |
|
2 |
1 |
2 |
0 |
Scopus |
17 |
0 |
5 |
3 |
2 |
|
2 |
|
2 |
1 |
2 |
0 |
282. |
2233969 |
Design and synthesis of novel N-benzylidenesulfonohydrazide inhibitors of MurC and
MurD as potential antibacterial agents |
1.01 |
Molecules |
2008 |
WoS |
16 |
2 |
0 |
|
1 |
1 |
|
4 |
6 |
1 |
1 |
|
Scopus |
17 |
2 |
0 |
1 |
1 |
1 |
|
3 |
7 |
1 |
1 |
|
283. |
3274353 |
Immunomodulatory properties of novel nucleotide oligomerization domain 2 (Nod2) agonistic
desmuramyldipeptides |
1.01 |
J. med. chem. |
2012 |
WoS |
16 |
0 |
1 |
0 |
1 |
3 |
0 |
6 |
2 |
2 |
1 |
|
Scopus |
17 |
0 |
1 |
1 |
1 |
3 |
0 |
6 |
2 |
2 |
1 |
|
284. |
3023985 |
Inhibitors of aldo-keto reductases AKR1C1-AKR1C4 |
1.02 |
Curr. med. chem. |
2011 |
WoS |
16 |
2 |
2 |
4 |
1 |
2 |
1 |
1 |
0 |
|
3 |
|
Scopus |
17 |
2 |
1 |
5 |
1 |
2 |
1 |
1 |
|
|
4 |
|
285. |
8189049 |
Benzoic acid derivatives with improved antifungal activity: design, synthesis, structure-activity
relationship (SAR) and CYP53 docking studies |
1.01 |
Bioorg. med. chem. |
2015 |
WoS |
16 |
|
|
|
2 |
2 |
3 |
|
|
5 |
4 |
|
Scopus |
17 |
|
|
|
2 |
2 |
4 |
|
|
5 |
4 |
|
286. |
61513987 |
Recent advances on smart glycoconjugate vaccines in infections and cancer |
1.02 |
FEBS j. |
2022 |
WoS |
16 |
|
|
|
|
|
|
|
|
2 |
14 |
|
Scopus |
17 |
|
|
|
|
|
|
|
|
4 |
13 |
|
287. |
2564721 |
Recent advances in the synthesis and applications of reduced amide pseudopeptides |
1.02 |
Curr. med. chem. |
2009 |
WoS |
17 |
1 |
1 |
1 |
2 |
4 |
2 |
3 |
1 |
2 |
|
|
Scopus |
16 |
1 |
1 |
1 |
2 |
3 |
4 |
|
2 |
2 |
|
|
288. |
3666289 |
Branched [alpha]-D-mannopyranosides; a new class of potent FimH antagonists |
1.01 |
MedChemComm |
2014 |
WoS |
16 |
|
|
1 |
1 |
3 |
3 |
2 |
1 |
3 |
2 |
|
Scopus |
17 |
|
|
1 |
1 |
3 |
4 |
2 |
1 |
3 |
2 |
|
289. |
15755267 |
N-alkylpiperidine carbamates as potential anti-Alzheimer's agents |
1.01 |
Eur. j. med. chem. |
2020 |
WoS |
16 |
|
|
|
|
|
|
|
|
8 |
8 |
|
Scopus |
17 |
|
|
|
|
|
|
|
|
9 |
8 |
0 |
290. |
1537274819 |
1,3-diamine-derived bifunctional organocatalyst prepared from camphor |
1.01 |
Advanced Synthesis & Catalysis |
2016 |
WoS |
16 |
|
|
|
|
2 |
4 |
2 |
5 |
1 |
2 |
|
Scopus |
17 |
|
|
|
|
3 |
3 |
3 |
5 |
1 |
2 |
|
291. |
2281300 |
The anatomy of the fruit in relation to the propensity of citrus species to split |
1.01 |
Sci. hortic. |
2001 |
WoS |
15 |
2 |
2 |
|
1 |
3 |
1 |
|
1 |
2 |
3 |
|
Scopus |
17 |
2 |
2 |
2 |
1 |
2 |
1 |
|
1 |
2 |
4 |
|
292. |
10746708 |
Comparison of flow cytometry, fluorescence microscopy and spectrofluorometry for analysis
of gene electrotransfer efficiency |
1.01 |
J. membr. biol. |
2014 |
WoS |
15 |
|
|
0 |
3 |
1 |
1 |
|
3 |
4 |
3 |
|
Scopus |
17 |
|
|
0 |
4 |
3 |
1 |
|
3 |
4 |
2 |
|
293. |
15647491 |
The tructural integrity of the model lipid membrane during induced lipid peroxidation |
1.01 |
Antioxidants |
2020 |
WoS |
15 |
|
|
|
|
|
|
|
1 |
9 |
5 |
|
Scopus |
17 |
|
|
|
|
|
|
|
1 |
9 |
5 |
2 |
294. |
3900273 |
Fagopyrins and protofagopyrins |
1.02 |
J. agric. food chem. |
2015 |
WoS |
17 |
|
|
|
1 |
1 |
2 |
1 |
1 |
6 |
5 |
|
Scopus |
15 |
|
|
|
1 |
1 |
1 |
1 |
1 |
5 |
5 |
|
295. |
58884867 |
Emerging glyco-based strategies to steer immune responses |
1.02 |
FEBS j. |
2021 |
WoS |
15 |
|
|
|
|
|
|
|
|
3 |
12 |
|
Scopus |
17 |
|
|
|
|
|
|
|
|
4 |
13 |
|
296. |
30078937 |
Selective inhibitors of aldo-keto reductases AKR1C1 and AKR1C3 discovered by virtual
screening of a fragment library |
1.01 |
J. med. chem. |
2012 |
WoS |
14 |
2 |
1 |
2 |
|
2 |
|
1 |
2 |
1 |
3 |
|
Scopus |
17 |
2 |
1 |
4 |
|
2 |
|
1 |
2 |
1 |
4 |
|
297. |
4279665 |
Endocrine activity of AVB, 2MR, BHA and their mixtures |
1.01 |
Toxicol. sci. |
2017 |
WoS |
14 |
|
|
|
|
|
1 |
1 |
4 |
6 |
2 |
|
Scopus |
17 |
|
|
|
|
|
1 |
1 |
5 |
7 |
2 |
1 |
298. |
11793492 |
Modular Serial Flow Through device for pulsed electric field treatment of the liquid
samples |
1.01 |
Sci. rep. |
2017 |
WoS |
14 |
|
|
|
|
|
|
1 |
4 |
4 |
4 |
1 |
Scopus |
17 |
|
|
|
|
|
|
1 |
6 |
5 |
4 |
1 |
299. |
3274609 |
MurD enzymes from different bacteria: evaluation of inhibitors |
1.01 |
Biochem. pharmacol. |
2012 |
WoS |
13 |
1 |
0 |
|
1 |
1 |
|
5 |
1 |
1 |
3 |
|
Scopus |
17 |
1 |
1 |
1 |
2 |
1 |
1 |
3 |
2 |
1 |
4 |
|
300. |
3726193 |
Synthesis and fluorescence properties of environment-sensitive 7-(diethylamino)coumarin
derivatives |
1.01 |
Tetrahedron lett. |
2014 |
WoS |
16 |
|
|
1 |
1 |
3 |
1 |
6 |
2 |
|
2 |
|
Scopus |
16 |
|
|
1 |
2 |
3 |
1 |
4 |
3 |
1 |
1 |
|
301. |
2959473 |
Structure guided development of potent reversibly binding penicillin binding protein
inhibitors |
1.01 |
ACS Medicinal Chemistry Letters |
2011 |
WoS |
16 |
5 |
2 |
1 |
3 |
|
2 |
1 |
0 |
2 |
|
|
Scopus |
16 |
4 |
2 |
1 |
3 |
1 |
2 |
1 |
0 |
2 |
|
|
302. |
2739825 |
MTHFR and TYMS genotypes influence TPMT activity and its differential modulation in
males and females |
1.01 |
Clin. biochem. |
2010 |
WoS |
15 |
|
1 |
4 |
3 |
1 |
2 |
3 |
|
|
1 |
|
Scopus |
16 |
|
1 |
4 |
2 |
2 |
2 |
2 |
1 |
1 |
1 |
|
303. |
4641905 |
Harnessing the untapped potential of NOD ligands for cancer immunotherapy |
1.02 |
Med. res. rev. |
2019 |
WoS |
15 |
|
|
|
|
|
|
|
4 |
8 |
3 |
|
Scopus |
16 |
|
|
|
|
|
|
|
4 |
8 |
3 |
1 |
304. |
3355505 |
Advances in the synthesis of morpholin-3-ones and morpholin-2-ones |
1.02 |
Synthesis |
2012 |
WoS |
15 |
1 |
|
|
|
|
|
3 |
1 |
5 |
5 |
|
Scopus |
16 |
1 |
|
1 |
|
|
|
4 |
3 |
2 |
5 |
|
305. |
38244355 |
Cyclic boronates as versatile scaffolds for KPC-2 ß-lactamase inhibition |
1.01 |
RSC med. chem. |
2020 |
WoS |
15 |
|
|
|
|
|
|
|
0 |
11 |
4 |
|
Scopus |
16 |
|
|
|
|
|
|
|
0 |
12 |
4 |
|
306. |
4358513 |
NMR Methods for identification of false positives in biochemical screens |
1.02 |
J. med. chem. |
2017 |
WoS |
15 |
|
|
|
|
|
1 |
5 |
6 |
1 |
2 |
|
Scopus |
16 |
|
|
|
|
1 |
3 |
4 |
6 |
1 |
1 |
|
307. |
4769905 |
Organoruthenated nitroxoline derivatives impair tumor cell invasion through inhibition
of cathepsin B activity |
1.01 |
Inorg. chem. |
2019 |
WoS |
15 |
|
|
|
|
|
|
0 |
4 |
8 |
3 |
|
Scopus |
16 |
|
|
|
|
|
|
0 |
4 |
8 |
4 |
|
308. |
3063409 |
Determination of raloxifene and its glucuronides in human urine by liquid chromatography-tandem
mass spectrometry assay |
1.01 |
Journal of chromatography |
2011 |
WoS |
14 |
3 |
1 |
2 |
2 |
2 |
|
|
2 |
1 |
1 |
|
Scopus |
16 |
4 |
1 |
2 |
2 |
2 |
|
1 |
2 |
1 |
1 |
|
309. |
3858033 |
Molecular dynamics to enhance structure-based virtual screening on cathepsin B |
1.01 |
J. comput.-aided mol. des. |
2015 |
WoS |
14 |
|
|
|
1 |
2 |
1 |
1 |
4 |
3 |
1 |
1 |
Scopus |
16 |
|
|
|
1 |
2 |
1 |
1 |
4 |
3 |
2 |
2 |
310. |
2858353 |
A novel scalable synthesis of pramipexole |
1.01 |
Org. process res. dev. |
2010 |
WoS |
14 |
|
2 |
2 |
2 |
1 |
1 |
2 |
4 |
|
|
|
Scopus |
16 |
|
2 |
2 |
2 |
1 |
1 |
2 |
4 |
1 |
1 |
|
311. |
3861873 |
Stereochemistry of amino acid spacers determines the pharmacokinetics of 111In-DOTA-minigastrin
analogues for targeting of the CCK2/gastrin receptor |
1.01 |
Bioconjug. chem. |
2015 |
WoS |
14 |
|
|
|
1 |
2 |
2 |
1 |
4 |
4 |
0 |
|
Scopus |
16 |
|
|
1 |
1 |
2 |
2 |
1 |
5 |
4 |
0 |
|
312. |
6255642 |
High performance thin-layer chromatography-mass spectrometry enables reliable analysis
of physalins in different plant parts of Physalis alkekengi L. |
1.01 |
J. chromatogr., A |
2017 |
WoS |
14 |
|
|
|
|
|
0 |
3 |
6 |
1 |
3 |
1 |
Scopus |
16 |
|
|
|
|
|
0 |
4 |
7 |
2 |
2 |
1 |
313. |
2982769 |
Synthesis and biological evaluation of a diazepanone-based library of liposidomycins
analogs as MraY inhibitors |
1.01 |
Eur. j. med. chem. |
2011 |
WoS |
16 |
1 |
3 |
3 |
0 |
1 |
1 |
2 |
1 |
2 |
2 |
|
Scopus |
14 |
1 |
3 |
3 |
0 |
|
1 |
2 |
1 |
1 |
2 |
|
314. |
2360177 |
Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and
MurD ligases |
1.01 |
ChemMedChem |
2008 |
WoS |
14 |
|
1 |
2 |
0 |
5 |
1 |
2 |
3 |
|
|
|
Scopus |
16 |
0 |
1 |
2 |
0 |
6 |
1 |
3 |
3 |
|
|
|
315. |
5462810 |
Inhibitor design strategy based on an enzyme structural flexibility |
1.01 |
J. chem. inf. mod. |
2014 |
WoS |
14 |
|
0 |
3 |
2 |
2 |
|
3 |
3 |
1 |
|
|
Scopus |
16 |
|
0 |
3 |
2 |
2 |
1 |
2 |
4 |
1 |
1 |
|
316. |
4512625 |
Preservative efficacy of selected antimicrobials of natural origin in a cosmetic emulsion |
1.01 |
Int. j. cosmet. sci. |
2018 |
WoS |
14 |
|
|
|
|
|
|
2 |
1 |
4 |
6 |
1 |
Scopus |
16 |
|
|
|
|
|
|
2 |
1 |
7 |
5 |
1 |
317. |
4051057 |
Characterization of endogenous sodium channels in the ND7-23 neuroblastoma cell line |
1.01 |
Assay drug dev. technol. |
2016 |
WoS |
14 |
|
|
|
|
2 |
4 |
2 |
4 |
1 |
1 |
|
Scopus |
16 |
|
|
|
1 |
2 |
5 |
2 |
4 |
1 |
1 |
|
318. |
3733128 |
Randomized clinical trial |
1.01 |
Journal of functional foods |
2016 |
WoS |
12 |
|
|
|
|
1 |
2 |
|
2 |
5 |
2 |
|
Scopus |
16 |
|
|
|
1 |
1 |
2 |
2 |
2 |
5 |
3 |
|
319. |
1057620 |
Low temperature influence on flowering in Citrus. The separation of inductive and
bud dormancy releasing effects |
1.01 |
Physiol. Plant. |
1992 |
WoS |
16 |
3 |
2 |
|
|
|
2 |
4 |
2 |
2 |
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
320. |
3506033 |
Synthesis of conformationally constrained [gamma]-D-glutamyl-meso -diaminopimelic
acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1
(Nod1) |
1.01 |
Eur. j. med. chem. |
2013 |
WoS |
15 |
|
2 |
4 |
2 |
1 |
2 |
2 |
0 |
2 |
0 |
|
Scopus |
15 |
|
2 |
4 |
2 |
1 |
2 |
2 |
0 |
2 |
0 |
|
321. |
30074841 |
N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo/keto reductase
AKR1C3 |
1.01 |
Bioorg. med. chem. lett. |
2012 |
WoS |
15 |
3 |
2 |
3 |
1 |
2 |
|
|
1 |
1 |
2 |
|
Scopus |
15 |
3 |
2 |
3 |
1 |
2 |
|
|
1 |
1 |
2 |
|
322. |
1836145 |
Design, synthesis and structure-activity relationships of new phosphinate inhibitors
of MurD |
1.01 |
Bioorg. med. chem. lett. |
2005 |
WoS |
15 |
|
1 |
|
|
2 |
|
5 |
5 |
2 |
|
|
Scopus |
15 |
0 |
1 |
|
|
2 |
1 |
4 |
5 |
2 |
|
|
323. |
2673521 |
A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering |
1.01 |
BMC Genomics |
2009 |
WoS |
15 |
|
2 |
2 |
|
1 |
2 |
2 |
4 |
1 |
1 |
|
Scopus |
15 |
|
2 |
2 |
|
1 |
1 |
2 |
5 |
1 |
1 |
|
324. |
3075441 |
A novel fluorescent probe for more effective monitoring of nanosized drug delivery
systems within the cells |
1.01 |
Int. j. pharm. |
2011 |
WoS |
14 |
3 |
1 |
4 |
2 |
|
2 |
1 |
|
|
1 |
|
Scopus |
15 |
3 |
2 |
4 |
2 |
|
2 |
1 |
|
|
1 |
|
325. |
22583811 |
Recent advances in the synthesis of acylboranes and their widening applicability |
1.02 |
ACS omega |
2020 |
WoS |
14 |
|
|
|
|
|
|
|
|
8 |
6 |
|
Scopus |
15 |
|
|
|
|
|
|
|
1 |
8 |
6 |
|
326. |
3977585 |
A quantum chemical study of the reactivity of acetaminophen (paracetamol) toxic metabolite
N-acetyl-p-benzoquinone imine with deoxyguanosine and glutathione |
1.01 |
Chem.-biol. interact. |
2015 |
WoS |
15 |
|
|
|
1 |
3 |
4 |
0 |
3 |
2 |
2 |
|
Scopus |
14 |
|
|
|
1 |
2 |
4 |
0 |
4 |
1 |
2 |
|
327. |
4307825 |
Enrofloxacin degradation in broiler chicken manure under field conditions and its
residuals effects to the environment |
1.01 |
Environ. sci. pollut. res. int. |
2017 |
WoS |
13 |
|
|
|
|
1 |
|
2 |
1 |
3 |
4 |
2 |
Scopus |
15 |
|
|
|
|
1 |
|
3 |
1 |
3 |
5 |
2 |
328. |
2982513 |
Preparation and reactivity of 5-benzylidenebarbituric and 5-benzylidene-2-thiobarbituric
acids |
1.01 |
Acta chim. slov. |
2011 |
WoS |
13 |
2 |
2 |
2 |
2 |
|
1 |
1 |
1 |
|
2 |
|
Scopus |
15 |
2 |
2 |
2 |
3 |
|
2 |
1 |
|
1 |
2 |
|
329. |
4145009 |
Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2 |
1.01 |
Bioorg. med. chem. |
2016 |
WoS |
12 |
|
|
|
|
1 |
2 |
1 |
5 |
1 |
2 |
|
Scopus |
15 |
|
|
|
|
1 |
2 |
1 |
5 |
2 |
4 |
|
330. |
3595633 |
Molecular docking revealed potential disruptors of glucocorticoid receptor-dependent
reporter gene expression |
1.01 |
Toxicol. lett. |
2014 |
WoS |
12 |
|
|
1 |
1 |
3 |
2 |
3 |
1 |
1 |
|
|
Scopus |
15 |
|
|
1 |
2 |
3 |
1 |
3 |
2 |
2 |
|
1 |
331. |
3742833 |
From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity |
1.01 |
Pharmacogenomics |
2014 |
WoS |
12 |
|
|
|
1 |
2 |
2 |
2 |
3 |
2 |
|
|
Scopus |
15 |
|
|
1 |
1 |
2 |
3 |
2 |
4 |
2 |
|
|
332. |
2224753 |
Comparison of capillary electrophoresis and high performance liquid chromatography
for determination of flavonoids in Achillea millefolium |
1.01 |
J. pharm. biomed. anal. |
2008 |
WoS |
12 |
1 |
4 |
1 |
1 |
|
2 |
|
1 |
1 |
1 |
|
Scopus |
15 |
1 |
4 |
1 |
1 |
|
2 |
3 |
1 |
1 |
1 |
|
333. |
28803331 |
Folate insufficiency due to MTHFR deficiency Is bypassed by 5-Methyltetrahydrofolate |
1.01 |
J. clin. med. |
2020 |
WoS |
12 |
|
|
|
|
|
|
|
|
4 |
8 |
|
Scopus |
15 |
|
|
|
|
|
|
|
|
5 |
10 |
|
334. |
3086449 |
Differences among Epilobium and Hypericum species revealed by four IR spectroscopy
modes: transmission, KBr tablet, diffuse reflectance and ATR |
1.01 |
Phytochem. anal. |
2011 |
WoS |
12 |
2 |
1 |
1 |
1 |
0 |
1 |
3 |
1 |
1 |
1 |
|
Scopus |
15 |
3 |
1 |
1 |
1 |
|
3 |
3 |
1 |
1 |
1 |
|
335. |
3257201 |
Simple modification of Karl-Fischer titration method for determination of water content
in colored samples |
1.01 |
Journal of Analytical Methods in Chemistry (Print) |
2012 |
WoS |
11 |
|
|
|
|
1 |
|
|
|
1 |
8 |
1 |
Scopus |
15 |
|
|
|
|
|
1 |
3 |
1 |
1 |
7 |
2 |
336. |
2380657 |
99mTc-labelled rituximab, a new non-Hodgkin's lymphoma, imaging agent: first clinical
experience |
1.01 |
Nucl Med Commun |
2008 |
WoS |
10 |
2 |
2 |
1 |
1 |
1 |
|
1 |
2 |
|
|
|
Scopus |
15 |
3 |
2 |
2 |
2 |
2 |
|
1 |
2 |
1 |
|
|
337. |
61605123 |
Discovery of K V 1.3 ion channel inhibitors |
1.02 |
Med. res. rev. |
2021 |
WoS |
9 |
|
|
|
|
|
|
|
|
3 |
6 |
|
Scopus |
15 |
|
|
|
|
|
|
|
|
3 |
8 |
4 |
338. |
38330627 |
Bicyclic boronates as potent inhibitors of AmpC, the class C ß-lactamase from escherichia
coli |
1.01 |
Biomolecules |
2020 |
WoS |
14 |
|
|
|
|
|
|
|
3 |
6 |
5 |
|
Scopus |
14 |
|
|
|
|
|
|
|
3 |
6 |
5 |
|
339. |
3151985 |
Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol
moiety |
1.01 |
PloS one |
2011 |
WoS |
14 |
3 |
3 |
|
3 |
1 |
|
1 |
2 |
0 |
1 |
|
Scopus |
14 |
3 |
3 |
|
3 |
1 |
|
1 |
2 |
0 |
0 |
1 |
340. |
33050371 |
Triclocarban, triclosan, bromochlorophene, chlorophene, and climbazole effects on
nuclear receptors |
1.01 |
Environ. health perspect. |
2020 |
WoS |
13 |
|
|
|
|
|
|
|
|
7 |
6 |
|
Scopus |
14 |
|
|
|
|
|
|
|
|
7 |
6 |
1 |
341. |
3526257 |
Isoform selective voltage-gated sodium channel modulators and the therapy of pain |
1.02 |
Curr. med. chem. |
2014 |
WoS |
13 |
|
1 |
2 |
1 |
1 |
2 |
|
2 |
|
4 |
|
Scopus |
14 |
|
1 |
3 |
1 |
|
3 |
|
2 |
|
4 |
|
342. |
35836931 |
Vaccinomics and adversomics in the era of precision medicine |
1.02 |
J. clin. med. |
2020 |
WoS |
13 |
|
|
|
|
|
|
|
|
7 |
6 |
|
Scopus |
14 |
|
|
|
|
|
|
|
|
8 |
5 |
1 |
343. |
4522609 |
A patent review of immunoproteasome inhibitors |
1.02 |
Expert opin. ther. pat. |
2018 |
WoS |
13 |
|
|
|
|
|
2 |
2 |
4 |
2 |
3 |
|
Scopus |
14 |
|
|
|
|
|
2 |
2 |
4 |
2 |
3 |
1 |
344. |
2326897 |
Comparative study of robustness between micellar electrokinetic capillary chromatography
and high-performance liquid chromatography using one- variable-at-a-time and a new
multi-variable-at-a-time approach |
1.01 |
Anal. chim. acta |
2008 |
WoS |
14 |
1 |
3 |
1 |
1 |
4 |
1 |
|
1 |
1 |
1 |
|
Scopus |
13 |
1 |
3 |
1 |
1 |
4 |
1 |
|
1 |
|
1 |
|
345. |
4874609 |
Synthesis, antiproliferative effect and topoisomerase II inhibitory activity of 3-methyl-2-phenyl-1H-indoles |
1.01 |
ACS Medicinal Chemistry Letters |
2020 |
WoS |
13 |
|
|
|
|
|
|
|
1 |
5 |
7 |
|
Scopus |
14 |
|
|
|
|
|
|
|
1 |
5 |
8 |
|
346. |
2152561 |
Activity or mass concentration of bone-specific alkaline phosphatase as a marker of
bone formation |
1.01 |
Clin Chem Lab Med |
2007 |
WoS |
13 |
|
2 |
|
4 |
4 |
|
1 |
1 |
1 |
|
|
Scopus |
14 |
|
2 |
|
4 |
4 |
|
3 |
|
1 |
|
|
347. |
3870833 |
D-Glucosamine in iron-catalysed cross-coupling reactions of Grignards with allylic
and vinylic bromides |
1.01 |
Appl. organomet. chem. |
2015 |
WoS |
14 |
|
|
1 |
2 |
2 |
5 |
3 |
0 |
1 |
|
|
Scopus |
13 |
|
|
1 |
2 |
2 |
5 |
2 |
0 |
1 |
|
|
348. |
3647601 |
Bazedoxifene scaffold-based mimetics of solomonsterols A and B as novel pregnane X
receptor antagonists |
1.01 |
J. med. chem. |
2014 |
WoS |
13 |
|
|
0 |
1 |
1 |
3 |
2 |
4 |
1 |
1 |
|
Scopus |
14 |
|
|
0 |
1 |
1 |
3 |
1 |
6 |
1 |
1 |
|
349. |
4364145 |
FT-IR-based method for rutin, quercetin and quercitrin quantification in different
buckwheat (Fagopyrum) species |
1.01 |
Sci. rep. |
2017 |
WoS |
12 |
|
|
|
|
|
1 |
1 |
5 |
2 |
3 |
|
Scopus |
14 |
|
|
|
|
|
2 |
2 |
5 |
3 |
2 |
|
350. |
21449689 |
Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKC1C1 |
1.01 |
Mol. cell. endocrinol. |
2006 |
WoS |
14 |
2 |
3 |
0 |
1 |
1 |
1 |
|
2 |
1 |
3 |
|
Scopus |
12 |
1 |
2 |
0 |
1 |
1 |
1 |
|
2 |
0 |
4 |
|
351. |
2990449 |
Small molecule inhibitors of peptidoglycan synthesis targeting the lipid II precursor |
1.01 |
Biochem. pharmacol. |
2011 |
WoS |
11 |
1 |
3 |
0 |
2 |
1 |
|
1 |
1 |
1 |
1 |
|
Scopus |
14 |
1 |
4 |
1 |
3 |
1 |
|
1 |
1 |
1 |
1 |
|
352. |
6031276 |
On-cartridge preparation and evaluation of 68Ga-, 89Zr- and 64Cu-precursors for cell
radiolabelling |
1.01 |
Nucl. med. biol. |
2019 |
WoS |
13 |
|
|
|
|
|
|
|
3 |
8 |
2 |
|
Scopus |
13 |
|
|
|
|
|
|
|
4 |
7 |
2 |
|
353. |
3026289 |
Virtual screening for potential inhibitors of bacterial MurC and MurD ligases |
1.01 |
J. mol. model. |
2012 |
WoS |
13 |
2 |
3 |
|
2 |
1 |
1 |
|
2 |
2 |
|
|
Scopus |
13 |
2 |
3 |
|
2 |
1 |
1 |
|
2 |
2 |
|
|
354. |
25314777 |
Trihydroxynaphthalene reductase of Curvularia lunata-A target for flavonoid action? |
1.08 |
Chem.-biol. interact. |
2009 |
WoS |
13 |
2 |
|
1 |
2 |
2 |
1 |
1 |
2 |
|
2 |
|
Scopus |
13 |
2 |
|
1 |
2 |
2 |
1 |
1 |
2 |
|
2 |
|
355. |
3871601 |
In silico and in vitro investigation of the piperineʼs male contraceptive effect |
1.01 |
Planta Med. |
2015 |
WoS |
13 |
|
|
|
2 |
2 |
4 |
3 |
|
2 |
|
|
Scopus |
13 |
|
|
1 |
2 |
2 |
3 |
3 |
|
2 |
|
|
356. |
4899185 |
Rational design to biologics development |
1.02 |
Int. j. pharm. |
2020 |
WoS |
13 |
|
|
|
|
|
|
|
0 |
4 |
9 |
|
Scopus |
13 |
|
|
|
|
|
|
|
0 |
5 |
7 |
1 |
357. |
31483609 |
New antagonists of toll-like receptor 7 discovered through 3D ligand-based virtual
screening |
1.01 |
Med. Chem. Res. |
2015 |
WoS |
12 |
|
|
|
1 |
2 |
|
4 |
2 |
1 |
2 |
|
Scopus |
13 |
|
|
|
1 |
2 |
|
4 |
3 |
|
3 |
|
358. |
2612849 |
S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases
6-mercaptopurine cytotoxicity in MOLT lymphoblasts |
1.01 |
Biochem. pharmacol. |
2009 |
WoS |
12 |
2 |
2 |
1 |
1 |
1 |
3 |
1 |
|
|
1 |
|
Scopus |
13 |
2 |
2 |
2 |
0 |
1 |
2 |
3 |
|
|
1 |
|
359. |
3210097 |
Post-translational stabilization of thiopurine S-methyltransferase by S-adenosyl-L-methionine
reveals regulation of TPMT*1 and *3C allozymes |
1.01 |
Biochem. pharmacol. |
2012 |
WoS |
12 |
1 |
1 |
2 |
0 |
3 |
1 |
1 |
1 |
2 |
|
|
Scopus |
13 |
1 |
1 |
3 |
0 |
3 |
1 |
1 |
1 |
2 |
|
|
360. |
4041329 |
Structural requirements of acylated Gly-l-Ala-d-Glu analogs for activation of the
innate immune receptor NOD2 |
1.01 |
Eur. j. med. chem. |
2016 |
WoS |
12 |
|
|
|
|
1 |
2 |
3 |
1 |
4 |
1 |
|
Scopus |
13 |
|
|
|
0 |
1 |
3 |
2 |
1 |
4 |
2 |
|
361. |
4483697 |
Discovery of nanomolar desmuramylpeptide agonists of the innate immune receptor nucleotide-binding
oligomerization domain-containing protein 2 (NOD2) possessing immunostimulatory properties |
1.01 |
J. med. chem. |
2018 |
WoS |
13 |
|
|
|
|
|
|
4 |
2 |
5 |
2 |
|
Scopus |
12 |
|
|
|
|
|
0 |
4 |
2 |
3 |
3 |
|
362. |
7153881 |
Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C
tyrosine phosphatase |
1.01 |
J. exp. med. |
1996 |
WoS |
12 |
|
1 |
2 |
2 |
|
2 |
|
4 |
|
1 |
|
Scopus |
13 |
1 |
1 |
2 |
3 |
|
2 |
1 |
2 |
|
|
1 |
363. |
38339075 |
Broad spectrum ß-lactamase inhibition by a thioether substituted bicyclic boronate |
1.01 |
ACS infect. dis. |
2020 |
WoS |
12 |
|
|
|
|
|
|
|
0 |
8 |
4 |
|
Scopus |
13 |
|
|
|
|
|
|
|
0 |
9 |
4 |
|
364. |
24011815 |
Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies
and tumor necrosis factor alpha |
1.01 |
Appl. environ. microbiol. |
2010 |
WoS |
11 |
1 |
1 |
1 |
4 |
2 |
0 |
0 |
|
2 |
0 |
|
Scopus |
13 |
1 |
3 |
1 |
4 |
2 |
0 |
0 |
|
2 |
0 |
|
365. |
1565276 |
Highly stereoselective formal synthesis of rosuvastatin and pitavastatin through Julia-Kocienski
olefination using the lactonized statin side-chain precursor |
1.01 |
Synthesis |
2014 |
WoS |
11 |
|
|
6 |
1 |
2 |
|
|
1 |
1 |
|
|
Scopus |
13 |
|
|
6 |
1 |
2 |
1 |
|
2 |
|
1 |
|
366. |
3391601 |
Towards dual antithrombotic compounds - Balancing thrombin inhibitory and fibrinogen
GPIIb/IIIa binding inhibitory activities of 2,3-dihydro-1,4-benzodioxine derivatives
through regio- and stereoisomerism |
1.01 |
Eur. j. med. chem. |
2013 |
WoS |
11 |
0 |
|
5 |
0 |
1 |
|
2 |
1 |
1 |
1 |
|
Scopus |
13 |
0 |
|
6 |
0 |
1 |
1 |
2 |
1 |
1 |
1 |
|
367. |
4249201 |
Inhibition of cathepsin X reduces the strength of microglial-mediated neuroinflammation |
1.01 |
Neuropharmacology |
2017 |
WoS |
10 |
|
|
|
|
|
4 |
1 |
3 |
1 |
1 |
|
Scopus |
13 |
|
|
|
|
2 |
4 |
2 |
3 |
1 |
1 |
|
368. |
4712561 |
DPP-4 inhibition |
1.02 |
Pharmacol. ther. |
2019 |
WoS |
10 |
|
|
|
|
|
|
2 |
4 |
3 |
1 |
|
Scopus |
13 |
|
|
|
|
|
|
1 |
6 |
4 |
2 |
|
369. |
21591299 |
The removal of bisphenols and other contaminants of emerging concern by hydrodynamic
cavitation |
1.01 |
Sci. total environ. |
2020 |
WoS |
9 |
|
|
|
|
|
|
|
|
2 |
6 |
1 |
Scopus |
13 |
|
|
|
|
|
|
|
|
3 |
9 |
1 |
370. |
3742577 |
Association of ITPA genotype with event-free survival and relapse rates in children
with acute lymphoblastic leukemia undergoing maintenance therapy |
1.01 |
PloS one |
2014 |
WoS |
9 |
|
|
|
2 |
|
1 |
|
3 |
1 |
2 |
|
Scopus |
13 |
|
|
1 |
2 |
|
2 |
0 |
5 |
1 |
2 |
|
371. |
13547267 |
Impact of nanoscale hindrances on the relationship between lipid packing and diffusion
in model membranes |
1.01 |
J. phys. chem., B (Online) |
2020 |
WoS |
12 |
|
|
|
|
|
|
|
4 |
4 |
4 |
|
Scopus |
12 |
|
|
|
|
|
|
|
4 |
3 |
4 |
1 |
372. |
3875953 |
Comparative evaluation of several docking tools for docking small molecule ligands
to DC-SIGN |
1.01 |
J. mol. model. |
2015 |
WoS |
12 |
|
|
|
1 |
6 |
3 |
1 |
|
1 |
0 |
|
Scopus |
12 |
|
|
|
1 |
5 |
3 |
2 |
|
1 |
0 |
|
373. |
4336753 |
Peptide microarray analysis of the cross-talk between O-GlcNAcylation and tyrosine
phosphorylation |
1.01 |
FEBS Letters |
2017 |
WoS |
12 |
|
|
|
|
|
3 |
1 |
2 |
4 |
2 |
|
Scopus |
12 |
|
|
|
|
|
3 |
1 |
2 |
5 |
1 |
|
374. |
67933443 |
Exploring protein hotspots by optimized fragment pharmacophores |
1.01 |
Nature communications |
2021 |
WoS |
12 |
|
|
|
|
|
|
|
|
2 |
10 |
|
Scopus |
12 |
|
|
|
|
|
|
|
|
2 |
10 |
|
375. |
13047555 |
Effect of estrogen-active compounds on the expression of RACK1 and immunological implications |
1.01 |
Arch Toxicol |
2020 |
WoS |
11 |
|
|
|
|
|
|
|
3 |
4 |
4 |
|
Scopus |
12 |
|
|
|
|
|
|
|
3 |
5 |
4 |
|
376. |
4050801 |
New N-phenyl-4,5-dibromopyrrolamides and N-phenylindolamides as ATPase inhibitors
of DNA gyrase |
1.01 |
Eur. j. med. chem. |
2016 |
WoS |
11 |
|
|
|
0 |
1 |
3 |
2 |
3 |
1 |
1 |
|
Scopus |
12 |
|
|
|
0 |
1 |
3 |
3 |
3 |
1 |
1 |
0 |
377. |
2520433 |
5,10-Methylenetetrahydrofolate reductase (MTHFR) low activity genotypes reducethe
risk of relapse-related acute lymphoblastic leukemia (ALL) |
1.01 |
Leuk. res. |
2009 |
WoS |
11 |
|
4 |
|
0 |
3 |
1 |
|
2 |
1 |
|
|
Scopus |
12 |
|
4 |
|
0 |
4 |
1 |
|
2 |
1 |
|
|
378. |
1438812 |
(Z)-5-(4-fluorophenyl)pent-4-enoic acid |
1.01 |
Synthesis |
2010 |
WoS |
11 |
2 |
1 |
1 |
3 |
|
|
|
2 |
1 |
1 |
|
Scopus |
12 |
2 |
1 |
1 |
3 |
|
|
|
2 |
1 |
2 |
|
379. |
5024538 |
Function of the D-Alanine:D-Alanine ligase lid loop |
1.01 |
J. med. chem. |
2012 |
WoS |
11 |
|
2 |
|
1 |
|
3 |
1 |
2 |
1 |
1 |
0 |
Scopus |
12 |
|
2 |
|
1 |
|
3 |
2 |
2 |
1 |
1 |
0 |
380. |
2165617 |
Synthesis of ethyl 3-(hydroxyphenoxy)benzyl butylphosphonates as potential antigen
85C inhibitors |
1.01 |
Tetrahedron |
2007 |
WoS |
11 |
|
|
|
2 |
1 |
|
1 |
1 |
4 |
2 |
|
Scopus |
12 |
|
|
1 |
2 |
1 |
|
1 |
1 |
4 |
2 |
|
381. |
80096771 |
Structural basis of prolyl hydroxylase domain inhibition by molidustat |
1.01 |
ChemMedChem |
2021 |
WoS |
11 |
|
|
|
|
|
|
|
|
4 |
7 |
|
Scopus |
12 |
|
|
|
|
|
|
|
|
3 |
9 |
|
382. |
4477553 |
Cathepsin B inhibitors |
1.01 |
Bioorg. med. chem. lett. |
2018 |
WoS |
12 |
|
|
|
|
|
0 |
1 |
2 |
5 |
4 |
|
Scopus |
11 |
|
|
|
|
|
0 |
1 |
2 |
4 |
4 |
|
383. |
32284931 |
Natural and synthetic derivatives of hydroxycinnamic acid modulating the pathological
transformation of amyloidogenic proteins |
1.02 |
Molecules |
2020 |
WoS |
11 |
|
|
|
|
|
|
|
|
3 |
8 |
|
Scopus |
12 |
|
|
|
|
|
|
|
|
3 |
8 |
1 |
384. |
3022961 |
Design, synthesis and biological evaluation of novel desmuramyldipeptide analogues |
1.01 |
Eur. j. med. chem. |
2011 |
WoS |
11 |
0 |
0 |
0 |
2 |
3 |
1 |
2 |
0 |
2 |
1 |
|
Scopus |
12 |
1 |
0 |
0 |
2 |
3 |
1 |
2 |
0 |
2 |
1 |
|
385. |
38810629 |
Discovery of Mycobacterium tuberculosis InhA inhibitors by binding sites comparison
and ligands prediction |
1.01 |
J. med. chem. |
2016 |
WoS |
10 |
|
|
|
|
0 |
3 |
1 |
3 |
1 |
2 |
|
Scopus |
12 |
|
|
|
|
0 |
3 |
1 |
5 |
0 |
2 |
1 |
386. |
8747092 |
The role of electrically stimulated endocytosis in gene electrotransfer |
1.01 |
Bioelectrochemistry |
2012 |
WoS |
10 |
|
5 |
1 |
1 |
|
|
|
|
2 |
1 |
|
Scopus |
12 |
|
5 |
2 |
1 |
|
1 |
|
|
2 |
1 |
|
387. |
5042298 |
Benzamide derivatives targeting the cell division protein FtsZ |
1.01 |
Antibiotics |
2020 |
WoS |
10 |
|
|
|
|
|
|
|
2 |
6 |
2 |
|
Scopus |
12 |
|
|
|
|
|
|
|
2 |
7 |
3 |
|
388. |
4863345 |
ATG12 deficiency leads to tumor cell oncosis owing to diminished mitochondrial biogenesis
and reduced cellular bioenergetics |
1.01 |
Cell death differ. |
2020 |
WoS |
9 |
|
|
|
|
|
|
|
2 |
3 |
4 |
|
Scopus |
12 |
|
|
|
|
|
|
|
3 |
4 |
5 |
|
389. |
23694041 |
Adsorption of radiopharmaceuticals to syringes |
1.01 |
Nucl Med Commun |
2007 |
WoS |
9 |
|
1 |
|
4 |
1 |
|
|
1 |
1 |
1 |
|
Scopus |
12 |
1 |
1 |
1 |
4 |
1 |
|
1 |
1 |
1 |
1 |
|
390. |
4051569 |
Crystallographic study of peptidoglycan biosynthesis enzyme MurD |
1.01 |
PloS one |
2016 |
WoS |
9 |
|
|
|
|
2 |
1 |
2 |
2 |
2 |
|
|
Scopus |
12 |
|
|
|
|
2 |
1 |
3 |
1 |
3 |
2 |
|
391. |
4397681 |
Endocrine disrupting activities and immunomodulatory effects in lymphoblastoid cell
lines of diclofenac, 4-hydroxydiclofenac and paracetamol |
1.01 |
Toxicol. lett. |
2018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Scopus |
12 |
|
|
|
|
|
|
2 |
4 |
4 |
2 |
|
392. |
2697073 |
Synthetic studies towards diazepanone scaffolds |
1.01 |
Tetrahedron: asymmetry |
2009 |
WoS |
11 |
|
3 |
3 |
1 |
|
2 |
2 |
|
|
|
|
Scopus |
11 |
|
3 |
3 |
1 |
|
2 |
2 |
|
|
|
|
393. |
1863025 |
Metabolism-directed optimisation of antithrombotics: the prodrug principle |
1.01 |
Curr. pharm. des. |
2006 |
WoS |
11 |
|
3 |
2 |
2 |
3 |
1 |
|
|
|
|
|
Scopus |
11 |
1 |
3 |
2 |
1 |
3 |
1 |
|
|
|
|
|
394. |
2366833 |
Synthesis of 1-C-linked diphosphate analogues of UDP-N-Ac-glucosamine and UDP-N-Ac-muramic
acid |
1.01 |
Tetrahedron |
2008 |
WoS |
11 |
1 |
1 |
|
1 |
1 |
1 |
|
2 |
2 |
2 |
|
Scopus |
11 |
1 |
1 |
|
1 |
1 |
1 |
|
1 |
2 |
3 |
|
395. |
3384689 |
Aromatic fluoro-de-triazenation with boron trifluoride diethyl etherate under non-protic
acid conditions |
1.01 |
J. fluorine chem. |
2013 |
WoS |
11 |
1 |
2 |
4 |
2 |
|
|
|
|
1 |
1 |
|
Scopus |
11 |
1 |
4 |
3 |
2 |
|
|
|
|
1 |
|
|
396. |
1536946115 |
Discovery of 'click' 1,2,3-triazolium salts as potential anticancer drugs |
1.01 |
Radiol. oncol. |
2016 |
WoS |
11 |
|
|
|
0 |
|
2 |
2 |
1 |
4 |
2 |
|
Scopus |
11 |
|
|
|
0 |
|
2 |
2 |
2 |
3 |
2 |
|
397. |
36732421 |
Synthesis of pyrazolo[1,2-a]pyrazole-based peptide mimetics |
1.01 |
Tetrahedron |
2013 |
WoS |
11 |
0 |
2 |
0 |
1 |
1 |
1 |
2 |
2 |
1 |
1 |
|
Scopus |
11 |
0 |
2 |
0 |
1 |
1 |
1 |
2 |
2 |
1 |
|
1 |
398. |
5563162 |
Evaluation of Michael-type acceptor reactivity of 5-benzylidenebarbiturates, 5-benzylidenerhodanines,
and related heterocycles using NMR |
1.01 |
Acta chim. slov. |
2014 |
WoS |
11 |
|
|
1 |
2 |
1 |
2 |
|
3 |
1 |
1 |
|
Scopus |
11 |
|
|
1 |
1 |
1 |
2 |
|
4 |
|
2 |
|
399. |
1563249 |
Solid-phase synthesis of amidines by the reduction of amidoximes |
1.01 |
Tetrahedron lett. |
2004 |
WoS |
11 |
|
|
2 |
2 |
2 |
|
1 |
1 |
1 |
2 |
|
Scopus |
11 |
|
|
2 |
2 |
2 |
|
1 |
1 |
1 |
2 |
|
400. |
3588465 |
2-Amino-5-alkylidenethiazol-4-ones as promising lipid peroxidation inhibitors |
1.01 |
Monatsh. Chem. |
2014 |
WoS |
11 |
|
1 |
2 |
|
3 |
2 |
1 |
2 |
|
|
|
Scopus |
11 |
|
1 |
2 |
|
3 |
2 |
1 |
2 |
|
|
|
401. |
30257369 |
Virtual screening yields inhibitors of novel antifungal drug target, benzoate 4-monooxygenase |
1.01 |
J. chem. inf. mod. |
2012 |
WoS |
10 |
|
1 |
1 |
2 |
|
|
1 |
3 |
1 |
1 |
|
Scopus |
11 |
|
1 |
3 |
1 |
|
1 |
|
3 |
1 |
1 |
|
402. |
25125123 |
DPP-4 inhibitors in the prevention/treatment of pulmonary fibrosis, heart and kidney
injury caused by covid-19-a therapeutic approach of choice in type 2 diabetic patients? |
1.01 |
Front Pharmacol |
2020 |
WoS |
11 |
|
|
|
|
|
|
|
1 |
6 |
4 |
|
Scopus |
10 |
|
|
|
|
|
|
|
1 |
7 |
2 |
|
403. |
3068017 |
Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5- triazin-2(1H)-ones
as inhibitors of cathepsin B |
1.01 |
Eur. j. med. chem. |
2011 |
WoS |
10 |
1 |
2 |
1 |
1 |
0 |
1 |
2 |
1 |
|
1 |
|
Scopus |
11 |
1 |
2 |
2 |
1 |
0 |
1 |
2 |
1 |
|
1 |
|
404. |
11691348 |
Cell stress response to two different types of polymer coated cobalt ferrite nanoparticles |
1.01 |
Toxicol. lett. |
2017 |
WoS |
9 |
|
|
|
|
1 |
3 |
0 |
2 |
1 |
2 |
|
Scopus |
11 |
|
|
|
|
1 |
3 |
1 |
3 |
2 |
1 |
|
405. |
5274906 |
Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus
faecium (Asl [sub] fm) |
1.01 |
Eur. j. med. chem. |
2013 |
WoS |
9 |
|
0 |
0 |
|
|
1 |
3 |
1 |
1 |
3 |
|
Scopus |
11 |
|
0 |
0 |
1 |
|
1 |
3 |
1 |
1 |
4 |
|
406. |
6615834 |
Structure-guided optimization of 4,6-substituted-1,3,5-triazin-2(1H)-ones as catalytic
inhibitors of human DNA topoisomerase II [alpha] |
1.01 |
Eur. j. med. chem. |
2019 |
WoS |
9 |
|
|
|
|
|
|
|
4 |
2 |
2 |
1 |
Scopus |
11 |
|
|
|
|
|
|
|
6 |
2 |
2 |
1 |
407. |
2622321 |
Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond |
1.02 |
Pharmacogenomics |
2009 |
WoS |
9 |
1 |
0 |
|
1 |
1 |
2 |
2 |
|
2 |
|
|
Scopus |
11 |
|
0 |
|
1 |
1 |
2 |
2 |
2 |
3 |
|
|
408. |
2374513 |
Surface active stabilizer Tyloxapol in colloidal dispersions exerts cytostatic effects
and apoptotic dismissal of cells |
1.01 |
Toxicol. appl. pharmacol. |
2008 |
WoS |
9 |
3 |
|
1 |
1 |
1 |
|
1 |
|
1 |
1 |
|
Scopus |
11 |
4 |
|
1 |
1 |
1 |
|
1 |
1 |
|
2 |
|
409. |
3367793 |
Influence of different types of commercially available microcrystalline cellulose
on degradation of perindopril erbumine and enalapril maleate in binary mixtures |
1.01 |
Acta pharm. |
2012 |
WoS |
9 |
|
1 |
|
|
|
1 |
2 |
|
3 |
2 |
|
Scopus |
11 |
|
2 |
|
|
1 |
1 |
2 |
|
3 |
2 |
|
410. |
27947481 |
Biochemical and biological evaluation of novel potent coumarin inhibitor of 17ß-HSD
type 1 |
1.08 |
Chem.-biol. interact. |
2011 |
WoS |
9 |
5 |
1 |
2 |
|
1 |
|
|
|
|
|
|
Scopus |
11 |
6 |
1 |
2 |
1 |
1 |
|
|
|
|
|
|
411. |
4892017 |
Anti-influenza virus activity of benzo[d]thiazoles that target heat shock protein
90 |
1.01 |
Bioorg. chem. |
2020 |
WoS |
8 |
|
|
|
|
|
|
|
4 |
2 |
2 |
|
Scopus |
11 |
|
|
|
|
|
|
|
5 |
2 |
4 |
|
412. |
3803505 |
Characterization of human lymphoblastoid cell lines as a novel in vitro test system
to predict the immunotoxicity of xenobiotics |
1.01 |
Toxicol. lett. |
2015 |
WoS |
7 |
|
|
1 |
|
2 |
2 |
|
1 |
1 |
|
|
Scopus |
11 |
|
|
2 |
|
3 |
2 |
|
1 |
2 |
|
1 |
413. |
3042161 |
Novel inhibitors of trihydroxynaphthalene reductase with antifungal activity identified
by ligand-based and structure-based virtual screening |
1.01 |
J. chem. inf. mod. |
2011 |
WoS |
6 |
2 |
|
2 |
1 |
|
1 |
|
|
|
|
|
Scopus |
11 |
3 |
1 |
3 |
1 |
2 |
1 |
|
|
|
|
|
414. |
7818580 |
Analysis and comparison of electrical pulse parameters for gene electrotransfer of
two different cell lines |
1.01 |
J. membr. biol. |
2010 |
WoS |
3 |
0 |
1 |
1 |
1 |
|
|
|
0 |
|
0 |
|
Scopus |
11 |
2 |
4 |
1 |
3 |
1 |
|
|
0 |
|
0 |
|
415. |
1629809 |
Peptidomimetic thrombin inhbibitors |
1.01 |
Pathophysiology of haemostasis and thrombosis |
2004 |
WoS |
11 |
|
2 |
1 |
2 |
2 |
|
|
1 |
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
416. |
86644739 |
Treatment of benign prostatic hyperplasia by natural drugs |
1.02 |
Molecules |
2021 |
WoS |
11 |
|
|
|
|
|
|
|
|
|
9 |
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
417. |
1863281 |
99mTc-rituximab radiolabelled by photo-activation: a new non-Hodgkins lymphoma imaging
agent |
1.01 |
Eur. j. nucl. med. mol. imaging |
2006 |
WoS |
10 |
|
2 |
2 |
1 |
4 |
|
1 |
|
|
|
|
Scopus |
10 |
|
3 |
2 |
1 |
3 |
|
1 |
|
|
|
|
418. |
4857457 |
In vitro estrogenic activity of binary and multicomponent mixtures with bisphenol
A |
1.01 |
Sci. total environ. |
2020 |
WoS |
10 |
|
|
|
|
|
|
|
1 |
4 |
5 |
|
Scopus |
10 |
|
|
|
|
|
|
|
3 |
2 |
5 |
|
419. |
47675139 |
WIDOCK |
1.01 |
J. comput.-aided mol. des. |
2021 |
WoS |
10 |
|
|
|
|
|
|
|
|
2 |
8 |
|
Scopus |
10 |
|
|
|
|
|
|
|
|
4 |
5 |
1 |
420. |
46272259 |
Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical
bifurcated halogen bonds |
1.01 |
Nature communications |
2021 |
WoS |
10 |
|
|
|
|
|
|
|
|
5 |
4 |
1 |
Scopus |
10 |
|
|
|
|
|
|
|
|
6 |
2 |
2 |
421. |
1647985 |
Recent advances in design, synthesis and biological activity of aminoalkylsulfonates
and sulfonamidopeptides |
1.01 |
Curr. med. chem. |
2004 |
WoS |
10 |
3 |
1 |
1 |
1 |
1 |
1 |
|
1 |
1 |
|
|
Scopus |
10 |
3 |
1 |
1 |
1 |
1 |
1 |
|
1 |
1 |
|
|
422. |
2985329 |
DC-SIGN ligation greatly affects dendritic cell differentiation from monocytescompromising
their normal function |
1.01 |
J. leukoc. biol. |
2011 |
WoS |
10 |
2 |
0 |
1 |
4 |
|
1 |
|
2 |
|
|
|
Scopus |
10 |
2 |
0 |
1 |
4 |
|
1 |
|
2 |
|
|
|
423. |
4616561 |
Methylation of selenocysteine catalysed by thiopurine S-methyltransferase |
1.01 |
Biochim. biophys. acta (G) |
2019 |
WoS |
10 |
|
|
|
|
|
|
2 |
2 |
4 |
2 |
|
Scopus |
10 |
|
|
|
|
|
|
2 |
1 |
5 |
2 |
|
424. |
4235633 |
Antibacterial and antibiofilm potentials of marine pyrrole-2-aminoimidazole alkaloids
and their synthetic analogs |
1.02 |
Mini rev. med. chem. |
2018 |
WoS |
10 |
|
|
|
|
|
|
|
4 |
1 |
5 |
|
Scopus |
10 |
|
|
|
|
|
|
|
4 |
2 |
4 |
|
425. |
4142961 |
New brominated flame retardants and their metabolites as activators of the pregnane
X receptor |
1.01 |
Toxicol. lett. |
2016 |
WoS |
9 |
|
|
|
|
1 |
2 |
4 |
0 |
1 |
1 |
|
Scopus |
10 |
|
|
|
|
1 |
2 |
4 |
0 |
2 |
1 |
|
426. |
1666161 |
Effect of preparation in solvent evaporation process on Eudragit RS microsphere properties |
1.01 |
Chem. Pharm. Bull. |
2005 |
WoS |
9 |
1 |
|
1 |
4 |
|
2 |
|
1 |
|
|
|
Scopus |
10 |
2 |
|
1 |
4 |
|
2 |
|
1 |
|
|
|
427. |
4869233 |
Development of potent reversible selective inhibitors of butyrylcholinesterase as
fluorescent probes |
1.01 |
J. enzyme inhib. med. chem. |
2020 |
WoS |
9 |
|
|
|
|
|
|
|
3 |
1 |
3 |
2 |
Scopus |
10 |
|
|
|
|
|
|
|
3 |
1 |
4 |
2 |
428. |
4494449 |
Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids |
1.01 |
MedChemComm |
2018 |
WoS |
10 |
|
|
|
|
|
|
1 |
3 |
5 |
1 |
|
Scopus |
9 |
|
|
|
|
|
|
1 |
2 |
5 |
1 |
|
429. |
31846915 |
Assessment of tractable cysteines by covalent fragments screenings |
1.01 |
ChemBioChem |
2021 |
WoS |
10 |
|
|
|
|
|
|
|
|
5 |
5 |
|
Scopus |
9 |
|
|
|
|
|
|
|
|
4 |
5 |
|
430. |
2988913 |
Cathepsin X cleavage of the ß2 integrin regulates talin-binding and LFA-1 affinity
in T cells |
1.01 |
J. leukoc. biol. |
2011 |
WoS |
9 |
1 |
1 |
2 |
|
1 |
1 |
0 |
|
2 |
1 |
|
Scopus |
10 |
1 |
1 |
2 |
|
1 |
1 |
0 |
|
3 |
1 |
|
431. |
2251377 |
Identification of herbarium whole-leaf samples of Epilobium species by ATR-IRspectroscopy |
1.01 |
Chem. biodivers. |
2008 |
WoS |
9 |
2 |
|
1 |
1 |
1 |
1 |
|
2 |
1 |
|
|
Scopus |
10 |
3 |
|
1 |
1 |
1 |
1 |
1 |
1 |
1 |
|
|
432. |
1499740 |
The use of a lactonized statin side-chain precursor in a concise and efficient assembly
of pitavastatin |
1.01 |
Synthesis |
2012 |
WoS |
9 |
1 |
2 |
5 |
|
|
|
|
1 |
|
|
|
Scopus |
10 |
1 |
2 |
5 |
|
|
|
|
1 |
|
1 |
|
433. |
4686193 |
Rutin as deoxyribonuclease I inhibitor |
1.01 |
Chem. biodivers. |
2019 |
WoS |
9 |
|
|
|
|
|
|
|
3 |
4 |
2 |
|
Scopus |
10 |
|
|
|
|
|
|
|
3 |
4 |
2 |
1 |
434. |
4738929 |
Efficient synthesis and preliminary biological evaluations of trifluoromethylated
imidazo[1,2-a]pyrimidines and benzimidazo[1,2-a]pyrimidines |
1.01 |
New j. chem. |
2019 |
WoS |
10 |
|
|
|
|
|
|
|
|
8 |
2 |
|
Scopus |
8 |
|
|
|
|
|
|
|
1 |
5 |
2 |
|
435. |
9424468 |
Electrofusion of B16-F1 and CHO cells |
1.01 |
Bioelectrochemistry |
2012 |
WoS |
8 |
1 |
1 |
0 |
0 |
0 |
2 |
1 |
|
|
3 |
|
Scopus |
10 |
0 |
1 |
1 |
0 |
1 |
1 |
1 |
|
1 |
4 |
|
436. |
81287683 |
Influence of linker attachment points on the stability and neosubstrate degradation
of cereblon ligands |
1.01 |
ACS Medicinal Chemistry Letters |
2021 |
WoS |
8 |
|
|
|
|
|
|
|
|
|
7 |
1 |
Scopus |
10 |
|
|
|
|
|
|
|
|
|
8 |
2 |
437. |
3477105 |
Biochemical characterization of MurF from Streptococcus pneumoniae and the identification
of a new MurF inhibitor through ligand-based virtual screening |
1.01 |
Acta chim. slov. |
2013 |
WoS |
10 |
|
0 |
1 |
|
4 |
|
|
3 |
1 |
1 |
|
Scopus |
8 |
|
0 |
|
|
4 |
|
|
2 |
|
2 |
|
438. |
4843121 |
Herbal preparations for the treatment of hair loss |
1.02 |
Arch. dermatol. res. |
2020 |
WoS |
8 |
|
|
|
|
|
|
|
|
2 |
6 |
|
Scopus |
10 |
|
|
|
|
|
|
|
|
2 |
8 |
|
439. |
6587988 |
Optimization of bulk cell electrofusion in vitro for production of human-mouse heterohybridoma
cells |
1.01 |
Bioelectrochemistry |
2008 |
WoS |
8 |
1 |
1 |
|
1 |
|
|
|
|
1 |
4 |
|
Scopus |
10 |
1 |
1 |
|
1 |
1 |
|
|
|
2 |
4 |
|
440. |
62365443 |
Overcoming challenges of HERG potassium channel liability through rational design |
1.02 |
Med. res. rev. |
2021 |
WoS |
8 |
|
|
|
|
|
|
|
|
3 |
5 |
|
Scopus |
10 |
|
|
|
|
|
|
|
|
3 |
5 |
2 |
441. |
3027569 |
Multitarget cardiovascular drugs |
1.02 |
Curr. med. chem. |
2011 |
WoS |
8 |
1 |
1 |
2 |
1 |
|
|
1 |
2 |
|
|
|
Scopus |
10 |
1 |
1 |
2 |
1 |
2 |
|
1 |
2 |
|
|
|
442. |
3086193 |
Commonly applied smoothing of IR spectra showed unappropriate for the identification
of plant leaf samples |
1.01 |
Chemometr. intell. lab. syst. |
2011 |
WoS |
7 |
|
0 |
|
1 |
3 |
|
1 |
1 |
|
1 |
|
Scopus |
10 |
|
0 |
1 |
1 |
4 |
|
1 |
1 |
|
2 |
|
443. |
4217713 |
Cardioprotective effects of silver fir (Abies alba) extract in ischemic-reperfused
isolated rat hearts |
1.01 |
Food & nutrition research |
2016 |
WoS |
7 |
|
|
|
|
0 |
|
3 |
1 |
2 |
1 |
|
Scopus |
10 |
|
|
|
|
0 |
|
2 |
3 |
2 |
3 |
|
444. |
89011971 |
Drug delivery strategies for curcumin and other natural Nrf2 modulators of oxidative
stress-related diseases |
1.02 |
Pharmaceutics |
2021 |
WoS |
7 |
|
|
|
|
|
|
|
|
|
7 |
|
Scopus |
10 |
|
|
|
|
|
|
|
|
|
7 |
3 |
445. |
2088817 |
Preparation of amidines by amidoxime reduction with potassium formate |
1.03 |
Synlett |
2007 |
WoS |
9 |
2 |
|
|
1 |
3 |
|
|
1 |
1 |
1 |
|
Scopus |
9 |
2 |
|
|
1 |
3 |
|
|
1 |
1 |
1 |
|
446. |
4654961 |
Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene
assays |
1.01 |
Chemosphere |
2019 |
WoS |
9 |
|
|
|
|
|
|
|
3 |
5 |
1 |
|
Scopus |
9 |
|
|
|
|
|
|
|
3 |
5 |
1 |
|
447. |
3081841 |
Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells |
1.01 |
Prostaglandins Other Lipid Mediat |
2011 |
WoS |
9 |
4 |
2 |
|
|
0 |
|
1 |
|
1 |
0 |
1 |
Scopus |
9 |
4 |
2 |
|
|
0 |
|
1 |
|
1 |
0 |
1 |
448. |
2505841 |
New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1
and AKR1C3 |
1.01 |
Eur. j. med. chem. |
2009 |
WoS |
9 |
0 |
1 |
2 |
1 |
2 |
|
1 |
|
1 |
1 |
|
Scopus |
9 |
0 |
1 |
2 |
1 |
2 |
|
1 |
|
1 |
1 |
|
449. |
4658033 |
An overview, advantages and therapeutic potential of non-peptide positive allosteric
modulators of glucagon-like peptide-1 receptor |
1.02 |
ChemMedChem |
2019 |
WoS |
9 |
|
|
|
|
|
|
|
4 |
4 |
1 |
|
Scopus |
9 |
|
|
|
|
|
|
1 |
3 |
4 |
1 |
|
450. |
2062705 |
Phosphinate Inhibitors of UDP-N-Acetylmuramoyl-L-Alanyl-D-Glutamate: L-Lysine Ligase
(MurE) |
1.01 |
Arch. Pharm. |
2007 |
WoS |
9 |
|
1 |
1 |
|
1 |
|
4 |
2 |
|
|
|
Scopus |
9 |
0 |
2 |
|
|
1 |
|
4 |
2 |
|
|
|
451. |
2068593 |
Higher frequency of the galactose-1-phosphate uridyl transferase gene K285N mutation
in the Slovenian population |
1.03 |
Clin. biochem. |
2007 |
WoS |
9 |
|
1 |
1 |
1 |
2 |
2 |
2 |
|
|
|
|
Scopus |
9 |
|
1 |
1 |
1 |
2 |
2 |
2 |
|
|
|
|
452. |
3500145 |
Antimicrobial activity and cytotoxicity of some 2-amino-5-alkylidene-thiazol-4-ones |
1.01 |
Molecular diversity |
2013 |
WoS |
9 |
|
0 |
2 |
1 |
|
2 |
1 |
2 |
1 |
|
|
Scopus |
9 |
|
0 |
2 |
1 |
|
2 |
1 |
2 |
1 |
|
|
453. |
4900977 |
Design and synthesis of 3,5-substituted 1,2,4-oxadiazoles as catalytic inhibitors
of human DNA topoisomerase II[alpha] |
1.01 |
Bioorg. chem. |
2020 |
WoS |
9 |
|
|
|
|
|
|
|
1 |
2 |
6 |
|
Scopus |
9 |
|
|
|
|
|
|
|
1 |
2 |
6 |
|
454. |
28563161 |
Neutrophil defensins but not interleukin-6 in vaginal fluid after preterm premature
rupture of membranes predict fetal/neonatal inflammation and infant neurological impairment |
1.01 |
Acta obstet. gynecol. Scand. |
2011 |
WoS |
8 |
1 |
1 |
3 |
|
|
|
|
2 |
1 |
|
|
Scopus |
9 |
1 |
1 |
3 |
1 |
|
1 |
|
1 |
1 |
|
|
455. |
4896625 |
Synthesis and evaluation of anticancer activity of new 9-acridinyl amino acid derivatives |
1.01 |
RSC med. chem. |
2020 |
WoS |
8 |
|
|
|
|
|
|
|
1 |
1 |
5 |
1 |
Scopus |
9 |
|
|
|
|
|
|
|
1 |
1 |
6 |
1 |
456. |
4360049 |
Clathrodin, hymenidin and oroidin, and their synthetic analogues as inhibitors of
the voltage-gated potassium channels |
1.01 |
Eur. j. med. chem. |
2017 |
WoS |
9 |
|
|
|
|
|
2 |
2 |
1 |
2 |
2 |
|
Scopus |
8 |
|
|
|
|
|
2 |
2 |
|
2 |
2 |
|
457. |
23240451 |
Development of a stability-indicating analytical method for determination of venetoclax
using AQbD principles |
1.01 |
ACS omega |
2020 |
WoS |
8 |
|
|
|
|
|
|
|
|
5 |
2 |
1 |
Scopus |
9 |
|
|
|
|
|
|
|
|
3 |
5 |
1 |
458. |
6391066 |
HPTLC-densitometric and HPTLC-MS methods for analysis of flavonoids |
1.01 |
J. liq. chromatogr. relat. technol. |
2018 |
WoS |
8 |
|
|
|
|
|
|
2 |
2 |
3 |
|
1 |
Scopus |
9 |
|
|
|
|
|
|
2 |
2 |
4 |
|
1 |
459. |
5145882 |
The binding mode of second-generation sulfonamide inhibitors of MurD |
1.01 |
PloS one |
2012 |
WoS |
8 |
|
2 |
|
0 |
1 |
1 |
2 |
1 |
1 |
|
|
Scopus |
9 |
0 |
2 |
|
0 |
1 |
1 |
2 |
1 |
1 |
1 |
|
460. |
3331441 |
Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis |
1.01 |
Eur. j. med. chem. |
2012 |
WoS |
8 |
0 |
3 |
1 |
1 |
|
|
1 |
|
2 |
|
|
Scopus |
9 |
0 |
3 |
1 |
1 |
|
|
2 |
|
2 |
|
|
461. |
3165297 |
Synthesis and biological evaluation of potential new inhibitors of the bacterial transferase
MraY with a ß-ketophosphonate structure |
1.01 |
Organic and Biomolecular Chemistry |
2011 |
WoS |
9 |
3 |
1 |
1 |
2 |
|
|
|
|
1 |
1 |
|
Scopus |
8 |
2 |
1 |
1 |
2 |
|
|
|
1 |
|
1 |
|
462. |
1538414787 |
Half-sandwich Ir(III) and Os(II) complexes of pyridyl-mesoionic carbenes as potential
anticancer agents |
1.01 |
Organometallics |
2019 |
WoS |
8 |
|
|
|
|
|
|
|
2 |
6 |
|
|
Scopus |
9 |
|
|
|
|
|
|
|
2 |
6 |
1 |
|
463. |
4639601 |
Heterocyclic electrophiles as new MurA inhibitors |
1.01 |
Arch. Pharm. |
2018 |
WoS |
8 |
|
|
|
|
|
|
|
2 |
3 |
3 |
|
Scopus |
9 |
|
|
|
|
|
|
|
3 |
3 |
3 |
|
464. |
1555036 |
Study of chemoselective asymmetric hydrogenation of (1-bromo-1-alkenyl)boronicesters
with iridium-P^N complexes |
1.01 |
Tetrahedron |
2014 |
WoS |
8 |
|
1 |
|
2 |
1 |
|
1 |
1 |
1 |
1 |
|
Scopus |
9 |
|
1 |
|
2 |
1 |
1 |
|
1 |
2 |
1 |
|
465. |
1943665 |
Glycerolipids as selective thrombin inhibitors from the fungus Stereum Hirsutum |
1.01 |
Drug dev. ind. pharm. |
2006 |
WoS |
8 |
2 |
2 |
|
|
|
|
2 |
|
1 |
1 |
|
Scopus |
9 |
2 |
2 |
|
|
|
|
2 |
|
2 |
1 |
|
466. |
1552241 |
Internucleosomal DNA cleavage in apoptotic WEHI 231 cells is mediated by a chymotrypsin-like
protease |
1.01 |
Genes cells |
2004 |
WoS |
7 |
1 |
1 |
1 |
1 |
|
|
1 |
1 |
|
1 |
|
Scopus |
9 |
1 |
1 |
2 |
1 |
1 |
|
1 |
1 |
|
1 |
|
467. |
15039491 |
Anomalies detected during hydrodynamic cavitation when using salicylic acid dosimetry
to measure radical production |
1.01 |
Chem. eng. j. |
2020 |
WoS |
7 |
|
|
|
|
|
|
|
|
2 |
4 |
1 |
Scopus |
9 |
|
|
|
|
|
|
|
1 |
1 |
6 |
1 |
468. |
29153795 |
Discovery of novel Hsp90 C-terminal inhibitors using 3D-pharmacophores derived from
molecular dynamics simulations |
1.01 |
Int. j. mol. sci. |
2020 |
WoS |
7 |
|
|
|
|
|
|
|
|
3 |
4 |
0 |
Scopus |
9 |
|
|
|
|
|
|
|
|
3 |
5 |
1 |
469. |
3193713 |
Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis:
potential implications in metabolism of progesterone and dydrogesterone and inhibition
by progestins |
1.01 |
J Steroid Biochem Mol Biol |
2012 |
WoS |
9 |
0 |
1 |
0 |
2 |
1 |
|
|
1 |
2 |
2 |
|
Scopus |
7 |
0 |
1 |
0 |
2 |
1 |
|
|
|
1 |
2 |
|
470. |
4657777 |
Synthesis of thicolchicine - based conjugates |
1.01 |
ChemPlusChem |
2019 |
WoS |
6 |
|
|
|
|
|
|
1 |
2 |
1 |
2 |
|
Scopus |
9 |
|
|
|
|
|
|
1 |
2 |
1 |
3 |
2 |
471. |
3577713 |
Ligand- and structure-based virtual screening for clathrodin-derived human voltage-gated
sodium channel modulators |
1.01 |
J. chem. inf. mod. |
2013 |
WoS |
8 |
|
0 |
0 |
1 |
0 |
2 |
1 |
|
2 |
2 |
|
Scopus |
8 |
|
0 |
0 |
1 |
0 |
2 |
1 |
|
2 |
2 |
|
472. |
27754457 |
Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients |
1.01 |
Transplant. proc. |
2010 |
WoS |
8 |
|
3 |
1 |
|
1 |
1 |
|
1 |
1 |
|
|
Scopus |
8 |
|
3 |
1 |
|
1 |
1 |
|
1 |
1 |
|
|
473. |
3497585 |
Coumarin-based dual fluorescent spin-probes |
1.01 |
Tetrahedron lett. |
2013 |
WoS |
8 |
|
2 |
|
1 |
3 |
|
|
1 |
1 |
|
|
Scopus |
8 |
|
2 |
|
1 |
3 |
|
|
1 |
1 |
|
|
474. |
4724337 |
New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors |
1.01 |
MedChemComm |
2019 |
WoS |
8 |
|
|
|
|
|
|
|
3 |
4 |
1 |
|
Scopus |
8 |
|
|
|
|
|
|
|
3 |
3 |
2 |
|
475. |
992625 |
Influence of chirality of the preceding acyl moiety on the cis/trans ratio of the
proline peptide bond |
1.01 |
J. org. chem. |
2001 |
WoS |
8 |
|
3 |
|
1 |
|
1 |
|
1 |
1 |
1 |
|
Scopus |
8 |
|
3 |
|
1 |
|
1 |
1 |
|
1 |
1 |
|
476. |
4642161 |
Analogs of the lignan pinoresinol as novel lead compounds for P-glycoprotein (P-gp)
inhibitors |
1.01 |
ACS Medicinal Chemistry Letters |
2018 |
WoS |
8 |
|
|
|
|
|
|
1 |
2 |
4 |
1 |
|
Scopus |
8 |
|
|
|
|
|
|
1 |
2 |
4 |
1 |
|
477. |
3642481 |
Antioxidant activity and phenolic content of Bergenia crassifolia, B. x ornata and
B. ciliata |
1.01 |
Natural product communications |
2014 |
WoS |
8 |
|
|
1 |
2 |
2 |
2 |
1 |
|
|
|
|
Scopus |
8 |
|
|
0 |
2 |
3 |
2 |
1 |
|
|
|
|
478. |
1537675459 |
Construction of vicinal tetrasubstituted stereogenic centers via a Mannich-type organocatalyzed
addition of [Delta] [sup] 2-pyrrolin-4-ones to isatine imines |
1.01 |
Advanced Synthesis & Catalysis |
2018 |
WoS |
8 |
|
|
|
|
|
2 |
2 |
3 |
|
1 |
|
Scopus |
8 |
|
|
|
|
|
2 |
2 |
3 |
|
1 |
|
479. |
4477809 |
Discovery of isatin and 1H-indazol-3-ol derivatives as D-amino acid oxidase (DAAO)
inhibitors |
1.01 |
Bioorg. med. chem. |
2018 |
WoS |
8 |
|
|
|
|
|
1 |
1 |
2 |
1 |
3 |
|
Scopus |
8 |
|
|
|
|
|
1 |
1 |
2 |
1 |
3 |
|
480. |
1360220 |
Novel inhibitors of ß-ketoacyl-ACP reductase from Escherichia coli |
1.08 |
Chem.-biol. interact. |
2009 |
WoS |
8 |
0 |
1 |
|
|
|
2 |
2 |
1 |
2 |
|
|
Scopus |
8 |
0 |
1 |
|
|
|
2 |
2 |
1 |
2 |
|
|
481. |
1538522051 |
Pyridine wingtip in [Pd(Py-tzNHC) [sub] 2] [sup] 2+ complex is a proton shuttle in
the catalytic hydroamination of alkynes |
1.01 |
Org. lett. |
2020 |
WoS |
8 |
|
|
|
|
|
|
|
2 |
5 |
1 |
|
Scopus |
8 |
|
|
|
|
|
|
|
2 |
4 |
2 |
|
482. |
2510676 |
Model-based automated detection of mammalian cell colonies |
1.01 |
Phys. Med. Biol. |
2001 |
WoS |
7 |
|
|
1 |
|
1 |
1 |
1 |
1 |
1 |
1 |
|
Scopus |
8 |
|
1 |
1 |
|
1 |
1 |
1 |
1 |
1 |
1 |
|
483. |
1576796 |
A DMAP-catalyzed approach to the industrial-scale preparation of n-6-demethylated
9,10-dihydrolysergic acid methyl ester: a key cabergoline andpergolide precursor |
1.01 |
Org. process res. dev. |
2015 |
WoS |
7 |
|
|
|
1 |
2 |
2 |
|
|
1 |
1 |
|
Scopus |
8 |
|
|
|
1 |
2 |
1 |
|
2 |
1 |
1 |
|
484. |
4765297 |
Discovery of immunoproteasome inhibitors using large-scale covalent virtual screening |
1.01 |
Molecules |
2019 |
WoS |
7 |
|
|
|
|
|
|
|
2 |
3 |
2 |
|
Scopus |
8 |
|
|
|
|
|
|
|
2 |
4 |
2 |
|
485. |
31706329 |
Hypoglycemia in venlafaxine overdose |
1.03 |
Eur J Clin Pharmacol |
2015 |
WoS |
8 |
|
|
|
1 |
|
|
1 |
2 |
2 |
2 |
|
Scopus |
7 |
|
|
|
1 |
|
|
2 |
|
2 |
2 |
|
486. |
17380355 |
A facile synthesis of ligands for the von Hippel-Lindau E3 ligase |
1.01 |
Synthesis |
2020 |
WoS |
7 |
|
|
|
|
|
|
|
1 |
3 |
3 |
|
Scopus |
8 |
|
|
|
|
|
|
|
1 |
3 |
4 |
|
487. |
58066947 |
Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action
including inhibition of the enzyme butyrylcholinesterase and [gamma]-aminobutyric
acid transporters |
1.01 |
Eur. j. med. chem. |
2021 |
WoS |
7 |
|
|
|
|
|
|
|
|
1 |
6 |
|
Scopus |
8 |
|
|
|
|
|
|
|
|
1 |
6 |
1 |
488. |
3873649 |
An overview of recent dipeptidyl peptidase-IV inhibitors |
1.02 |
Curr. topics med. chem. |
2015 |
WoS |
7 |
|
|
|
1 |
1 |
3 |
1 |
|
|
1 |
|
Scopus |
8 |
|
|
|
1 |
2 |
2 |
1 |
|
|
2 |
|
489. |
3408212 |
Effect of surfactant polyoxyethylene glycol (C[sub]12E[sub]8) on electroporation of
cell line DC3F |
1.01 |
Colloids surf., A Physicochem. eng. asp. |
2003 |
WoS |
7 |
1 |
|
1 |
1 |
|
1 |
2 |
|
0 |
1 |
|
Scopus |
8 |
1 |
|
2 |
1 |
|
1 |
2 |
|
0 |
1 |
|
490. |
2480497 |
Derivatives of pyrimidine, phthalimide and anthranilic acid as inhibitors of human
hydroxysteroid dehydrogenase AKR1C1 |
1.08 |
Chem.-biol. interact. |
2009 |
WoS |
8 |
|
|
|
1 |
1 |
|
1 |
1 |
1 |
3 |
|
Scopus |
7 |
|
|
|
1 |
1 |
|
1 |
1 |
1 |
2 |
|
491. |
26759429 |
Reaction of methyl (2E)-3-dimethylamino-2-(1H-indol-3-yl)-propenoate with ureas |
1.01 |
Tetrahedron |
2005 |
WoS |
7 |
2 |
1 |
0 |
0 |
1 |
1 |
1 |
1 |
|
|
|
Scopus |
8 |
2 |
1 |
0 |
0 |
2 |
1 |
1 |
1 |
|
|
|
492. |
4360305 |
Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly
improved anti-tumor activity in vitro and in vivo |
1.01 |
Oncotarget |
2017 |
WoS |
8 |
|
|
|
|
|
1 |
4 |
1 |
2 |
0 |
|
Scopus |
7 |
|
|
|
|
|
2 |
2 |
1 |
2 |
0 |
|
493. |
25421317 |
A novel approach to substituted 1,3-selenazole core as a precursor of electron rich
olefins: diselendiazafulvalene and azino-diselenadiazafulvalene |
1.01 |
New j. chem. |
2003 |
WoS |
6 |
|
1 |
1 |
1 |
2 |
1 |
|
|
|
|
|
Scopus |
8 |
1 |
1 |
1 |
1 |
2 |
1 |
|
1 |
|
|
|
494. |
69036803 |
Targeted cancer therapy using compounds activated by light |
1.02 |
Cancers |
2021 |
WoS |
6 |
|
|
|
|
|
|
|
|
1 |
5 |
|
Scopus |
8 |
|
|
|
|
|
|
|
|
1 |
6 |
1 |
495. |
34389209 |
Selective Toll-like receptor 7 agonists with novel chromeno[3,4-d]imidazol-4(1H)-one
and 2-(trifluoromethyl)quinoline/ quinazoline-4-amine scaffolds |
1.01 |
Eur. j. med. chem. |
2019 |
WoS |
6 |
|
|
|
|
|
|
1 |
|
3 |
2 |
|
Scopus |
8 |
|
|
|
|
|
|
1 |
|
4 |
3 |
|
496. |
3843441 |
Chemistry of 2-aminoimidazoles |
1.02 |
J. heterocycl. chem. |
2016 |
WoS |
6 |
|
|
|
1 |
1 |
2 |
|
2 |
|
|
|
Scopus |
8 |
|
|
|
1 |
2 |
2 |
|
2 |
1 |
|
|
497. |
4371057 |
Repositioning drugs for rare immune diseases |
1.02 |
Curr. med. chem. |
2018 |
WoS |
6 |
|
|
|
|
|
|
1 |
2 |
2 |
1 |
|
Scopus |
8 |
|
|
|
|
|
1 |
1 |
2 |
2 |
2 |
|
498. |
34301957 |
The influence of electroporation on cytotoxicity of anticancer ruthenium(III) complex
KP1339 in vitro and in vivo |
1.01 |
Anticancer res. |
2010 |
WoS |
6 |
|
0 |
2 |
1 |
0 |
|
|
2 |
1 |
|
|
Scopus |
8 |
|
0 |
3 |
1 |
1 |
|
|
2 |
1 |
|
|
499. |
88347651 |
Herbal products used in menopause and for gynecological disorders |
1.02 |
Molecules |
2021 |
WoS |
6 |
|
|
|
|
|
|
|
|
|
5 |
1 |
Scopus |
8 |
|
|
|
|
|
|
|
|
|
6 |
2 |
500. |
3061361 |
Thrombin inhibitors with lipid peroxidation and lipoxygenase inhibitory activities |
1.01 |
Bioorg. med. chem. lett. |
2011 |
WoS |
5 |
|
|
1 |
2 |
|
|
1 |
1 |
|
|
|
Scopus |
8 |
|
|
2 |
2 |
|
1 |
1 |
2 |
|
|
|
501. |
2530161 |
Analysis of atorvastatin and related substances by MEKC |
1.01 |
Chromatographia |
2009 |
WoS |
5 |
1 |
1 |
|
|
1 |
|
1 |
|
1 |
|
|
Scopus |
8 |
2 |
1 |
|
1 |
1 |
|
2 |
|
1 |
|
|
502. |
1431665 |
Mutations in galactose-1-phosphate uridyltransferase gene in patients with idiopathic
presenile cataract |
1.01 |
J. inherit. metab. dis. |
2003 |
WoS |
4 |
|
1 |
|
|
1 |
|
1 |
|
1 |
|
|
Scopus |
8 |
|
3 |
|
|
1 |
|
2 |
1 |
1 |
|
|
503. |
2113393 |
Precision of micellar electrokinetic capillary chromatography in the determination
of seven antibiotics in pharmaceuticals and feedstuffs |
1.01 |
Anal. chim. acta |
2007 |
WoS |
7 |
2 |
|
|
3 |
|
2 |
|
|
|
|
|
Scopus |
7 |
2 |
|
|
3 |
|
2 |
|
|
|
|
|
504. |
4683633 |
New coumarin- and phenoxazine-based fluorescent probes for live-cell STED nanoscopy |
1.01 |
Eur. biophys. j. |
2019 |
WoS |
7 |
|
|
|
|
|
|
|
2 |
4 |
1 |
|
Scopus |
7 |
|
|
|
|
|
|
1 |
3 |
2 |
1 |
|
505. |
3085937 |
Discovery of highly potent, nonsteroidal 17ß-hydroxysteroid dehydrogenase type 1 inhibitors
by virtual high-throughput screening |
1.01 |
J Steroid Biochem Mol Biol |
2011 |
WoS |
7 |
1 |
1 |
|
|
3 |
1 |
1 |
|
|
|
|
Scopus |
7 |
1 |
1 |
|
|
3 |
2 |
|
|
|
|
|
506. |
3966577 |
STD NMR and molecular modelling insights into interaction of novel mannose-based ligands
with DC-SIGN |
1.01 |
Organic and Biomolecular Chemistry |
2016 |
WoS |
7 |
|
|
|
1 |
|
|
1 |
2 |
2 |
1 |
|
Scopus |
7 |
|
|
|
1 |
|
|
1 |
2 |
2 |
1 |
|
507. |
4076884 |
Shape transformation and burst of giant POPC unilamellar liposomes modulated by non-ionic
detergent C_12E_8 |
1.01 |
Chem. phys. lipids |
2003 |
WoS |
7 |
1 |
1 |
|
1 |
|
|
|
|
4 |
|
|
Scopus |
7 |
1 |
1 |
|
1 |
|
|
|
|
4 |
|
|
508. |
3958129 |
In silico discovery of novel potent antioxidants on the basis of pulvinic acid and
coumarine derivatives and their experimental evaluation |
1.01 |
PloS one |
2015 |
WoS |
7 |
|
|
|
|
2 |
|
0 |
4 |
1 |
|
|
Scopus |
7 |
|
|
|
1 |
1 |
|
0 |
3 |
2 |
|
|
509. |
1551473 |
Influence of herbicide, 2,4-dichlorophenoxy acetic acid, on haemocyte DNA of in vivo
treated mussel |
1.01 |
J. exp. mar. biol. ecol. |
2004 |
WoS |
7 |
|
1 |
|
2 |
2 |
1 |
1 |
|
|
|
|
Scopus |
7 |
|
1 |
|
2 |
2 |
1 |
1 |
|
|
|
|
510. |
3007601 |
Nitroxide-fluorophore double probes: a potential tool for studying membrane heterogeneity
by ESR and fluorescence |
1.01 |
Organic and Biomolecular Chemistry |
2011 |
WoS |
7 |
1 |
4 |
1 |
|
1 |
|
|
|
|
|
|
Scopus |
7 |
1 |
4 |
1 |
|
1 |
|
|
|
|
|
|
511. |
3398769 |
Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli
and evaluation of its immunogenicity |
1.01 |
Appl. microbiol. biotechnol. |
2013 |
WoS |
7 |
|
2 |
0 |
0 |
0 |
2 |
1 |
1 |
|
1 |
|
Scopus |
7 |
|
3 |
0 |
0 |
0 |
2 |
1 |
|